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Given that no country can afford the costs of all health-care programs which 
claim to have some benefits, cost-utility analysis (CUA) which compares the costs of 
an intervention with its benefits, is increasingly used for setting priorities. In CUA, 
the benefits are measured as quality-adjusted life-years (QALYs), which combines 
quantity of life with health-related quality-of-life (HRQoL) into a single measure. To 
calculate QALY values, health-state utilities (HSU) need to be used as HRQoL 
weights.  
 
Several research questions on HSU measurement are addressed. First, we 
compared the preference values of EQ-5D-5L health states between mainland Chinese 
and Singaporean Chinese. We found that Singaporean Chinese valued EQ-5D-5L 
health states with severe or extreme problems as much more undesirable than 
mainland Chinese. Second, we investigated whether the values of the EQ-5D-3L 
health states are the same to the general population and the patients of interest. For 
this purpose, we compared the TTO values of EQ-5D-3L health states directly elicited 
from patients with type 2 diabetes mellitus (T2DM) and the general population in 
Singapore. We found that the values of EQ-5D-3L states with mild health problems to 
T2DM patients were higher than to the general population, although these two 
populations valued the EQ-5D-3L states with severe health problems as similarly 
undesirable. Third, we developed an EQ-5D-3L value set using time trade-off (TTO) 
values directly measured from the general Singaporean population because there was 
 ix 
 
no local HSU value sets. Fourth, we developed functions to predict the SF-6D36 index 
score from the SF-8 health survey. Fifth, we compared the discriminative power of the 
SF-6D index score derived from the SF-36 and SF-12. We found the SF-36 provides a 
more discriminative preference-based health index than the SF-12. 
 
These studies have generated new knowledge on measuring HSUs and provided 
health service researchers with useful tools and guidance for obtaining HSU values.  
First, the much greater health benefit gained from a transition from a severe health 
state to a mild health to Singaporean Chinese than to mainland Chinese supports the 
practice of developing local EQ-5D-5L value sets. Second, the values of mild 
EQ-5D-3L health states are higher to T2DM patients than to the general population 
indicates that the EQ-5D-3L values based on the general population‟s preferences 
could be insensitive to the benefits of and underestimate the effectiveness of health 
inventions for T2DM. Hence, it may be worthwhile to determine the values of the 
EQ-5D-3L health states to patients with a certain condition. Third, the established 
EQ-5D-3L value set provides health services researchers in Singapore a useful tool to 
appraise the cost-effectiveness of health programs and technologies. Fourth, the 
functions developed for predicting the preference-based SF-6D36 index score from the 
psychometric instrument SF-8 enable the SF-8 data to be used in CUA. Fifth, the 
finding that the SF-6D derived from the SF-36 is more sensitive than that derived 
from the SF-12 supports the usage of the SF-6D index score derived from the SF-36 
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Chapter One - Introduction 
 
During the past three decades, cost-utility analysis (CUA) is increasingly used to 
inform resource allocation decisions (Torrance, 1986; Johannesson et al, 1996; 
Drummond et al, 2005). The CUA compares the incremental cost of a health 
intervention to the incremental health improvement reflecting preference attributed to 
the intervention. It is a form of economic appraisal method in which the health 
improvement is mainly measured in terms of quality-adjustment life-years (QALYs) 
gained (Torrance, 1986; Johannesson et al, 1996; Drummond et al, 2005). QALY 
incorporates both quantity and quality of life into a single generic measure by 
multiplying the length of life with quality-of-life weights. In the QALY approach, the 
quality-of-life weights are a set of health-state utilities (HSUs) (Torrance, 1986; 
Johannesson et al, 1996; Drummond et al, 2005). HSUs can also be applied in 
decision-analytic models for individual patients, clinical trials to evaluate new 
interventions, and population health surveys to compare population groups (Torrance, 
1987).  
 
HSU has the advantage of providing a single cardinal measure of health-related 
quality of life (HRQoL), suitable for quantitative and parametric statistical analysis 
(Torrance, 1987). Moreover, it is the only measure that can be used as quality-of-life 
weights since it captures the strength of individuals‟ preferences for various health 
states.  
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HSUs are cardinal values, reflecting the strength of individuals‟ preferences for health 
states, the more preferable a health state, the greater value the state has (Drummond et 
al, 2005). The cardinal characteristics of HSUs indicate equal intervals on the scale 
have the same interpretation. For example, health gains from 0.1 to 0.2 and 0.6 to 0.7 
on the scale are identical. HSUs should be based on individuals‟ preferences for 
health states. It should be noted that the composite scores generated from 
psychometric or profile-based quality-of-life instruments (e.g. SF-36), which are 
designed to discriminate different levels of health status, do not necessarily reflect 
individuals preferences (Johannesson et al, 1996). It is possible that two individuals 
have the same level of health but value that health state very differently. HSUs are 
anchored on full health and death. For convenience, full health and death have been 
given values of 1.0 and 0, respectively. The advantage of using 1.0 for full health in 
calculation of QALYs is that the resulting QALYs are measured in the unit of full 
health year, that is, 1 QALY is one year in full health, 0.5 QALY is half a year in full 
health, and so on. Health states can also be regarded as worse than death, and take on 
HSU values less than 0.   
 
When measuring HSUs, three core issues (i.e. how to define health states, how to 
measure HSUs values, and whose HSUs should be used) need to be addressed 
(Torrance, 1986; Dolan, 1999; Brazier and Ratcliffe, 2008). In the next sections, these 
issues will be reviewed. Subsequently, I will provide a description of the research 
objectives of the project. The last section of the chapter is a brief summary of studies 
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conducted to address the research objectives in this project.  
  
1. How to Define Health States  
Health states can be defined through two approaches (Brazier and Ratcliffe, 2008). 
One is to use bespoke descriptions of health states presented in forms of designed 
vignettes, text narrative or videos and audios. Another approach is to define health 
states using standardized health-state classification systems. A health-state 
classification system consists of a number of multilevel domains. Each health state is 
defined by combining different levels, one from each domain. Hence, a classification 
system contains a number of health states. The classification system can be generic, 
focusing on kernel aspects of health and can be used across all groups, or specific to a 
certain disease or condition. Taking the classification system of the EQ-5D-3L for 
example, the system has 5 dimensions (i.e. mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression) and each dimension has 3 functional levels 
(i.e. no problems, some problems, and extreme problems). Together it defines a total 




2. How to Measure HSU Values? 
HSU values can be obtained through valuation techniques such as the standard 
gamble (SG) (Torrance, 1986) and the time trade-off (TTO) (Torrance, 1972) and 
preference-based instruments such as the EQ-5D-3L (Dolan, 1997), the health utilities 
index (HUI) (Feeny et al, 2002), and the short form 6-dimensions (SF-6D) (Brazier et 
al, 2002). The HSU values can be directly measured from using SG or TTO, whereas 
the utility value for each health state defined by the classification system of 
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preference-based instruments is pre-determined. In other words, the utility values 
derived from preference-based instruments are not measured from study subjects. For 
this reason, the preference-based measures are referred to as indirect methods while 
the SG and TTO are named as the direct methods.  
 
2.1The Direct Method  
HSUs can be elicited through valuation techniques such as the SG and TTO. The 
visual analogue scale (VAS), although also be widely used in health-state valuation, is 
often criticized due to its scores being elicited in a choiceless context (Green et al, 
2000). Moreover, there is empirical evidence of a poor to moderate correlation 
between VAS values and SG and TTO values (Bakker et al, 1994, Rutten et al, 1995; 
Clake et al, 1997). Hence, VAS technique seems to measure health status but not the 
strength of preference for health states (Green et al, 2000). In current health-state 
valuation practices, VAS is often used as a warm up practice for respondents but not 
the formal method for eliciting HSUs. Therefore, only SG and TTO are introduced 
below.   
 
2.1.1 Standard Gamble 
The SG is the classical method for measuring cardinal preferences (Torrance, 1986). It 
is rooted in the fundamental axioms of expected utility theory (EUT) developed by 
von Neumann and Morgenstern (1953). The SG has been used extensively in medical 
decision-making analysis including health-state valuation. The core of the SG is to 
ask respondents to indicate preferences between a certain intermediate outcome and 
the uncertainty of a gamble with two possible outcomes: one is better than the certain 
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intermediate outcome while the other is worse.  
 
For health states regarded as better than death (SBTD), the respondent is offered two 
alternatives (Figure 1.1). Alternative one is a hypothetical treatment with two possible 
outcomes: either the respondent returns to full health (probability p), or the 
respondent dies immediately (probability 1-p). Alternative two is the certain outcome 
of living in that health state. The probability p is varied until the respondent is 
indifferent between the two alternatives, at which point the probability p is the utility 
value for the health state. For health states considered as worse than death (SWTD), 
the certain alternative is death, whereas the uncertain alternative is living in full health 
or that health state, with probability p or 1-p, respectively. Again, the p is varied until 
the indifference point is reached, at which point the utility value of the health state is 
–p/(1-p).   






















Health state valued 
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2.1.2 Time Trade-Off 
The TTO method was developed specifically for use in health care by Torrance et al 
(1972). It was designed as a simple-to-administer alternative to SG. Like the SG, it 
also asks respondents to choose between two alternatives. However, the two 
alternatives are both under certainty rather than a certain outcome and an uncertain 
gamble with two outcomes. Essentially, it involves a tradeoff between quantity and 
quality of life. For SBTD, one alternative is living in a certain period of time (x) in 
full health and then die; the other alternative is living in a fixed time (t) in the health 
state valued and then die. Time x is varied until the respondent is indifferent between 
the two alternatives, at which utility value of the health state is x/t. For SWTD, 
respondents are also presented with a choice between two alternatives. However, the 
first alternative is immediate death; the second alternative is time x (x<t) in the health 
state followed by full health until time t and then die. Again, time x is varied until the 
respondent is indifferent between the two alternatives, at which the utility value for 
the state is x-t/x.  
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2.1.3 More on Standard Gamble and Time Trade-Off 
The SG is directly rooted in EUT, which has been the dominant theory in 
decision-making under uncertainty since the 1950s (Dolan, 1999). It postulates a 
rational individual should make choice between uncertain outcomes in such a way as 
to obtain the maximum of their „expected‟ utility or satisfaction. According to the 
axioms, if a utility is expressed as equivalent to a gamble, it is a linear function of the 
risk involved in the gamble (Neumann and Morgenstern, 1953). Due to its link with 
EUT, the SG is often referred to as the „gold standard‟ for eliciting HSUs (Torrance 
and Feeny, 1989). However, the status of SG is often criticized by many researchers 
because of ample evidence for the violation of the axioms of EUT (Froberg and Kane, 
1989). For example, the SG values can be significantly influenced by the gamble 
outcomes in the tasks and the way the tasks presented (Llewellyn-Thomas et al, 1982). 
Furthermore, there is also evidence suggesting that people‟s risk attitude is not 
constant (Kahnerman and Tversky, 1982). Given the empirical violations of the 
axioms of EUT, the „gold standard‟ status of the SG for measuring HSUs may not be 
justifiable.  
 
Compared to the SG, the TTO has the advantage of being simpler to use. Buckingham 
and Devlin (2006) aligned the TTO with the welfare economic approach of 
Compensating Variations (CV) developed by Hicks (1943), where welfare gain is 
measured by compensating loss of something valuable so that the respondent is 
returned to their original level of welfare. In the TTO, the health improvement is 
valued by the corresponding length of life the respondent is prepared to sacrifice. The 
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SG can also be linked with the CV approach, in which the health improvement is 
valued in terms of the risk (i.e. immediate death) the respondent is prepared to accept. 
In this way, both the SG and TTO can be viewed as sharing a common theoretical 
background (Dolan et al, 1996). On the other hand, there are 3 main concerns about 
the TTO (Green et al, 2000; Brazier and Ratcliffe, 2008). The first is the lack of 
incorporation of uncertainty. Respondents in the task are asked to make a choice 
between two certain outcomes, while medical decision in health-care is characterized 
by its uncertainties. The second is the effect of duration. The TTO assumes that the 
proportion of remaining life years that individuals are willing to trade off for a 
specific health improvement is independent of the amount of remaining life. This is a 
very strong assumption and it seems reasonable to expect that the HSUs may be 
influenced by the duration effect relating to the time an individual spends in that state 
(Brazier and Ratcliffe, 2008). The third is the impact of time preference. Individuals 
may either have positive or negative time preference, meaning they would be either 
more willing to give up life years in the distant or near future (Drummond et al, 
2005).  
 
Both SG and TTO have many variants in terms of mode of administration (e.g. 
interview or self-administered, computer or paper-based), search procedures (e.g. 
iteration, titration), the use of prop and visual aids and so on (Torrance, 1987; Dolan 
et al, 1996; Brazier and Ratcliffe, 2008). Although the two techniques have many 
types of variants and are cognitive complex, there is empirical evidence to support the 
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practicality of the SG and TTO, with high completion and response rates reported, 
across different variants and various types of respondent groups (Green et al, 2000; 
Brazier and Ratcliffe, 2008). Moreover, both techniques demonstrate an acceptable 
level of test-retest reliability as evidenced by a wide variety of empirical studies 
(Froberg and Kane, 1989).  
 
Both SG and TTO have important problems in valuing SWTD. First, the valuation 
procedures for STWD of the two methods are fundamentally different from their 
procedures for SBTD. Switching between elicitation procedures for SBTD and 
SWTD increases the cognitive burden of the tasks for respondents. Second, the 
denominators are no longer a fixed number in the calculation of negative SG and TTO 
values, as opposed to the denominators in calculation of positive SG and TTO values. 
That means the values for SBTD and SWTD may not be measured with the same 
metric. Third, both techniques can generate extreme negative values and therefore ex 
post transformation of the negative values to be bounded by -1 is routinely performed 
in valuation studies using SG or TTO.  
 
To overcome the problems, recently, Robinson and Spencer proposed (2006) and 
Devlin et al (2011) further developed an approach that unifies the TTO valuation 
procedures for all health states, which termed as „lead-time TTO (LT-TTO)‟. The 
LT-TTO adds a „lead time‟ in full health preceding each of the two alternatives. The 
approach avoids the need to have different valuation procedures for SBTD and SWTD 
by allowing participants to trade the lead time provided. For any health state, the first 
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alternative is x years in full health and then die. The second alternative is z (e.g. 10) 
years in full health followed by y (e.g. 10) years in the health state and then die. As 
such, the utility value is (x-z)/y. In this case, the utility value will be positive, negative, 
or 0, depending on the values of (x-z). The approach was found to be a feasible and 
valid procedure for valuing EQ-5D-3L health states (Devlin et al, 2011) and would be 
a promising tool in health-state valuation.    
 
2.1.4 Discrete Choice Experiments  
The values generated from the SG or TTO may be distorted by factors such as risk 
aversion (SG), time preference (TTO) and so on (Brazier and Ratcliffe, 2008), 
indicating the values may not necessarily reflect people‟s preference over health states. 
Moreover, both the SG and TTO techniques are cognitively difficult for many 
respondents, resulting in response inconsistencies and subsequently data exclusions 
that limit representativeness of the values yielded. Hence, many health services 
researchers have begun to examine the discrete choice experiments (DCEs), which 
generate cardinal values from ordinal measurement, in health-state valuation.  
 
The DCEs are based on random utility theory (RUT) proposed by Thurston (1927) 
and extended by McFadden (1986). Unlike the SG and TTO, respondents in the DCE 
tasks do not need to go through an iterative process to identify the indifference point 
between two alternatives. In DCE tasks, each respondent is presented with two or 
more options and simply required to indicate their most or least preferred options. 
Through the conditional logistic regression, DCE data can provide estimates on the 
relative preferences of one option over another. DCE tasks are generally regarded as 
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easier to complete compared to the TTO and SG, and are often conducted without an 
interviewer through postal or on-line surveys (Brazier and Ratcliffe, 2008).  
 
In health-state valuation, several studies have used DCEs to estimate values for 
different health-state profiles, however, most of the values are not based on HSU scale, 
in which 0 is being dead and 1.0 is full health (Bosch JL et al, 1998; Coast et al, 2008). 
Hence, the DCE data in those studies cannot be directly used for calculation of 
QALYs. Brazier et al (2007) used DCE data to generate health-state values on the 
health utility scale for the EQ-5D-3L. The use of DCE, although at an early stage of 
development, offers a promising alternative to the SG and TTO in health-state 
valuation.  
 
2.2 The Indirect Method 
The valuation techniques (i.e. TTO and SG) are difficult to administer, cognitively 
demanding to respondents and resource-intensive to investigators. A widely used 
alternative is generic preference-based instruments which can be used to obtain HSU 
values much more easily. The instruments contain two components: a health-state 
classification system that classifies respondents into various health states using on a 
questionnaire and a scoring function for scoring these states. The scoring functions 
are usually established by two steps: first, a subset of possible health states from a 
classification system are measured using the TTO or SG from a representative sample 
of a general population; second, these HSU values are used to predict HSU values for 
all possible health states of the classification system.  




There is a wide choice of generic preference-based measures such as the EQ-5D-3L, 
the HUI marks 2, 3 (HUI2, HUI3), and the SF-6D, a derivative of the SF-36 and 
SF-12. Among them, the EQ-5D-3L has become most widely used, but others are also 
be used considerably (Fitzpatrick et al, 2006).  
 
2.2.1 EQ-5D-3L 
The EQ-5D-3L is a standardized instrument for use as a measure of health outcome 
developed by the EuroQol Group (Brooks, 1996). The EQ-5D-3L classification 
system consists of 5 domains: mobility, self-care, usual activities, pain/discomfort, 
and anxiety/depression, with each domain being described as three levels: „no 
problems‟ (level 1); „some problems‟ (level 2); and „severe problems‟ (level 3). The 
system therefore defines a total of 243 (3
5
) unique health states. The first scoring 
algorithm for the EQ-5D-3L health states was derived from the general UK 
population in the measurement and valuation of health (MVH) study using TTO 
technique and econometric modeling in 1997 (Dolan, 1997). Subsequently, a number 
of country-specific EQ-5D-3L algorithms were developed using a similar research 
protocol in other countries (Jelsma et al, 2003; Lamers et al, 2006; Shaw et al, 2007; 
Lee et al, 2009; Golicki et al, 2010). 
 
2.2.2 SF-6D 
The preference-based instrument SF-6D is a derivative of the SF-36 or SF-12 (an 
abbreviated version of SF-36 comprising 12 of the SF-36 items) (Brazier et al, 2002; 
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Brazier and Roberts, 2004). The two instruments, although have been widely used in a 
great number of studies, their scores are not preference-based and therefore cannot be 
used directly in CUA. The SF-6D provides an approach for converting the data 
collected by SF-36 or SF-12 to HSUs for CUA.  
 
The SF-6D classification system was developed from a selection of 11 SF-36 items 
(the SF-6D36), or 7 SF-12/36 items (the SF-6D12). The classification system of the two 
variants has 6 common domains including physical functioning, role limitations, 
social functioning, pain, mental health and vitality. The SF-6D36 assesses physical 
functioning, pain, and mental health in greater detail than the SF-6D12. Accordingly, 
the SF-6D12 and SF-6D36 define 7,500 and 18,000 unique health states, respectively. 
The scoring algorithms for SF-6D36 and SF-6D12 were constructed using the same 
random sample of the general UK population based on SG technique and econometric 
modeling method.  
 
2.2.3 HUI 
The HUI is a family of generic preference-based system for measuring comprehensive 
health status and HRQoL (Feeny et al, 1995; Torrance et al, 1995). There are currently 
two HUI systems: HUI2 and HUI3. The classification system of HUI2 consists of 6 
domains (i.e. sensation, mobility, emotion, cognition, self-care, and pain), each with 4 
to 5 levels. The HUI3 classification system has 8 domains: vision, hearing, speech, 
ambulation, dexterity, emotion, cognition, and pain, with 3 to 5 levels per domain. 
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The two systems define a total of 24,000, and 972,000 health states, respectively. The 
scoring functions for the two systems were based on SG values derived from random 
samples of the general Canadian population and estimated using a multiplicative 
model.  
 
Although these measures all claim to measure generic health, (i.e. important aspects 
of health appropriate for all populations), they do differ significantly in terms of the 
content and capacity of their classification system, valuation technique, source of 
population used to value health states, and scoring methods. A summary of the main 



















Table 1.1 Characteristics of the generic preference-based instruments  











   
Mobility (3) 
 
PF (6) PF (3) Mobility (5) 
Ambulation 
(6) 
AD (3)  MH (5) MH (5) Emotion (5) Emotion (5) 
PD (3)  BP (6) BP (5) Pain (5) Pain (5) 
UA (3)  SF (5) SF (5) Cognition (4) Cognition (6) 
Self-care (3)  RL (4) RL (4) Self-care (4) Dexterity (6) 
  Vitality (5) Vitality (5) Sensation (4) Hearing (6) 
     Speech (5) 
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PF – Physical functioning; MH – Mental health; BP – Bodily pain; SF – Social 
functioning; RL – Role limitations; AD – Anxiety/depression; PD – Pain/discomfort; 
UA – Usual activities. MAUT – multi-attribute utility theory  
 
Given the differences mentioned above, it is not surprising that these measures have 
produced different utility values for the same respondents (McDonough and Tosteson, 
2007). Then the question is how to select an appropriate instrument.  
 
In selecting an instrument, researchers should consider a number of factors including 
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feasibility, psychometric properties (i.e. validity, reliability, sensitivity and 
responsiveness), the degree of the overlap between the levels and dimensions of the 
classification system and the target population, respondent burden, overall cost of 
using the instrument and so on (Drummond et al, 2005).  
 
One issue regarding the instrument selection is the generalizability of HSU values 
from the instruments. Since the HSU values are initially scored based on one 
particular population, these values may not reflect people‟s value of health in other 
populations. Although some researchers replicated HSUs measurements (i.e. 
controlling for method) in different populations and found either no or little difference 
(Drummond et al, 2005), some other investigators showed that HSUs differed 
significantly across different populations in different countries (Norman et al, 2009). 
Hence, recent years have seen an increasing number of studies developing 
country-specific HSU value sets (Jelsma et al, 2003; Lamers et al, 2006; Shaw et al, 
2007; Lee et al, 2009; Golicki et al, 2010) 
  
A general limitation of generic preference-based instruments is that they may lack 
sensitivity and relevance to particular diseases or conditions. As a result, the 
disease-specific preference-based measures have started to emerge in the literature 
(Revicki et al, 1998; Yang et al, 2006; Brazier et al, 2008). However, it is questionable 
that whether the utility values from these measures are generalizable or comparable 
across different patient groups. These are important in economic evaluations in which 
the purpose is to inform resource allocation decisions across different patient groups. 
Ultimately, for both generic and disease-specific preference-based measures, there is a 
trade-off between the greater relevance and sensitivity of some and limited 





2.3 Mapping Health Profiles to Health-state Utilities 
HSU data collected by preference-based instruments may not always be available. In 
such situations, mapping, that is the development and use of a function (or functions) 
to predict HSU values using data on non-preference-based measure or profile-based 
measure, can be the solution (NICE, 2013). The data for predicting HSU values can 
be the condition-specific instruments (e.g. Parkinson‟s Disease Questionnaire), 
generic instruments (e.g. SF-36), clinical indicators of disease severity, 
socio-demographic variables or a combination of these.  
 
The approach involves using regression model to estimate the relationship between 
preference-based measure and profile-based measure and requires administration of 
the two measures to the same population, and sufficient similarity in item content 
between the two measures. Once the mapping function established, it can be applied 
to data collected using the profile-based measure to predict HSU values.  
  
Recent years have seen an increasing number of studies developing functions to 
predict preference scores from psychometric quality-of-life instruments. Such 
approach has been accepted as a valid method for yielding utility scores by National 
Institute for Health and Care Excellence (NICE) (2012). 
 
2.3.1 Model Specification  
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Mapping functions can be established using a number of specifications and different 
estimation methods. The most widely used model is additive model: the dependent 
variables can be the index scores of target preference-based instruments or dimension 
levels of the instruments; the independent variables can be the overall scores, 
dimension scores, item scores, or item responses to profile-based measure (Brazier et 
al, 2010). Among them, overall scores, dimension scores and item scores are treated 
as continuous variables but item responses are modeled as categorical variables and 
dummy variables are generated for each item response. To relax the assumptions of 
simple additive model, the square and interaction terms for dimension or item scores 
can also be included as independent variables. In addition, non-health variables such 
as age, gender and race can also be used as independent variables.  
 
2.3.2 Model Estimation  
The most common method of estimating mapping functions has been the ordinary 
least square (OLS) model (Brazier et al, 2010). However, the classical OLS 
assumptions are deviated and violated in many dataset which will generally cause the 
estimates to be biased, inconsistent and/or inefficient. For example, if the utility 
scores exhibit a ceiling effect, that is, a large proportion of respondents have a utility 
score of 1.0, the OLS model may lead to predicted values outside the theoretical range 
of the utility scale. Hence, researchers have explored alternatives of OLS model to 
overcome its limitations, including Tobit model, censored least absolute deviation 
(CLAD) model, latent-class model and two-part models which are appropriate for 
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censored or bounded data. For such data, these models were compared with OLS but 
the results were mixed with some indicating the CLAD and two-part models 
performed better than the OLS model (Sullivan and Ghushchyan, 2006), others 
concluding that the CLAD and OLS models had similar performance (Eleanor et al, 
2010).  
 
2.3.3 Model Performance  
Model performance can be assessed by a number of criteria such as consistency, bias, 
and precision. Consistency means the model should predict lower utility scores for 
more severe health problems. Precision is the accuracy of the predictions, which can 
be evaluated using a number of goodness-of-fit measures such as adjusted R
2
, mean 
error (ME), mean absolute error (MAE) and root mean squared error (RMSE). 
Adjusted R
2
 tells how well the model explains the variance of actual values in the 
estimation dataset, and the other measures examine the average difference between 
predicted and observed values and provide a quantitative view of the prediction errors. 
In addition, numbers or proportion of absolute errors greater or smaller than some 
thresholds (e.g. 0.05 or 5%) can also be used to compare models‟ performance. 
Prediction errors can be assessed at individual-level or aggregate-level. Bias refers to 
the pattern of prediction errors across the scale of the dependent variable. If there are 
systematic errors in the predictions, researchers need to consider the impact of the 
bias on the CUA. 
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A recent review of mapping studies suggested that mapping from condition-specific 
quality-of-life measure onto a generic preference-based measure has poorer model 
performance than mapping from generic quality-of-life measure onto a generic 
preference-based measure (Brazier et al, 2010). This is due to limited degree of 
overlap in item content between the preference-based measure and condition-specific 
measure as important dimensions of one measure may not be covered by the other. An 
alternative in these situations is to derive disease-specific preference-based measures.  
 
Ideally, model performance should be both assessed on the estimation dataset which is 
used to construct the model and on an external dataset similar to the estimation dataset. 
Nevertheless, it is not uncommon that the external dataset is unavailable. In that case, 
if the original dataset is large in size, it is recommended to randomly split the data 
into an „estimation‟ sample and a „validation‟ sample. The model is estimated on the 
„estimation‟ sample and its performance is checked using the „validation‟ sample. 
Once the model specification has been evaluated and determined, the final model can 
then be re-estimated using the full sample.  
 
The main advantage of mapping is that it enables HSU values to be predicted when 
only health profile data is available. However, as the mapping functions just predict 
rather than measure HSU values directly, which will lead to increased uncertainty and 
error for the estimated HSU values, using mapping functions is always a second best 
solution to using preference-based instruments.  
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3. Whose Health-state Utilities Should Be Used? 
HSUs can be elicited from different sources such as patient and general populations 
(Torrance, 1986). For the purpose of personal clinical decisions, it is clear that patient 
utilities should be used. On the other hand, for decisions about allocating societal 
resources, there is the question of whose utilities should be used and the question has 
been intensively debated in the literature (Boyd et al, 1990; Ulber et al, 2001; Brazier 
et al, 2005; Chapman et al, 2009). The question is of great importance as it may 
influence the resultant utility values. According to a meta-analysis, on average, there 
is no significant difference in HSUs between patient and general populations (Dolders 
et al, 2006); however, for some disease, differences do exist. A number of empirical 
studies have indicated that patients who are experiencing certain diseases tend to give 
higher health-state utilities than members of the general population (Sackett and 
Torrance, 1978; Llewellyn-Thomas et al, 1982; Boyd et al, 1990; Hurst et al, 1994), 
and the extent of this discrepancy tends to be much stronger when patients value their 
own health state (Brazier et al, 2005).  
 
The difference described above can have important consequences in CUA in health 
care. For example, if patients with colostomies rate their own HSU as 0.92 while 
those without colostomies estimate the utility of living with a colostomy as 0.80, and 
the magnitude of incremental gain from a treatment avoids the need for a colostomy 
and restores patients to full health (1.0) would be more than twice using utility value 
from the non-patients than patients with colostomies.  
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The difference could be attributed to various factors such as poor descriptions of 
health states to general population (Ulber et al, 2003), response shift (i.e. changes in 
internal standards of health) or adaptation (Ulber et al, 2003), and cognitive 
dissonance (Festinger L, 1957). 
 
3.1 General Population Health-state Utilities  
HSUs are normally obtained from members of the general population trying to 
imagine and value health states of patients. The main argument for the use of general 
population utility values is that societal resource allocation decisions should be made 
appealing to the whole society since the general population pays for healthcare 
services. Relatedly, if one of the purposes of the healthcare system is to give 
reassurance to the general public, resources should, in part, be allocated so as to 
reassure the public that treatment is available to alleviate the health problems they 
fear the most (Edgar et al, 1998). On the other hand, although members of the general 
public want to be involved in healthcare decision making, it is not clear whether 
HSUs or QALYs are their main considerations. Furthermore, members of the general 
population in the current valuation practice are relatively uninformed: they are 
unlikely to know about the consequences of disease and other changes. Hence, their 
values will not reflect what it is actually like to be in the health state. Nevertheless, 
the Washington Panel used the „veil of ignorance‟ to support the use of community 
values, where a rational public decides what is the best course of action when blind to 
its own self-interest. Aggregating the utilities of persons who have no vested interest 
in particular health states seems most appropriate (Gold et al, 1996). 
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3.2 Patient Health-state Utilities  
The argument for using patient values is that patients know their health states and the 
impact of their health problems better than those trying to imagine them. However, 
this would imply that society wants to incorporate all the changes and adaptations that 
occur in patients who experience states of ill health. Furthermore, there is evidence 
suggesting that patient values are not constant, and reflecting their recent experiences 
of ill health or the health of their relatives or close friends (Kind and Dolan, 1995). In 
addition, valuation techniques (i.e. SG, TTO) require respondents to compare their 
own state to full health, which patients may not have experienced for a long time. The 
tasks of imagining full health can be as difficult for patients as members of the 
general public imagining dysfunctional health states. 
 
In summary, it is difficult to justify the exclusive use of utility values from patients or 
members of the general public. The question of whose utility values should be used is 
a normative judgment. If it is accepted that, ultimately, the utility values of general 
population are required to inform resource allocation in a public system, the 
respondents should be provided with adequate information on what the states are like 
for patients experiencing them (Brazier et al, 2005). Meanwhile, empirical studies are 
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4. Research Objectives 
The overall object of the thesis was to develop and test various approaches to 
measuring health-state utilities for cost-utility analysis.  
 
The increasing application of CUA to evaluate cost-effectiveness of health 
interventions has led to an increased demand for HSUs for usage in various 
populations and settings. In Singapore, we recognized that there was no local HSU 
value sets and studies often use off-the-shelf HSU value sets developed from other 
populations (Luo et al, 2003a; Luo et al, 2003b; Luo et al, 2003c; Luo et al, 2009; 
Gao et al, 2009; Abdin et al, 2009; Zhang et al, 2009; Wang et al, 2012; Chong et al, 
2012). However, it is unlikely that HSU values are universal, although some studies 
do indicate the similarities of HSUs across countries (Wang et al, 2002; Le Gale et al, 
2002). Hence, the first objective of this project was to compare the HSU values of 
Singaporeans and mainland Chinese, and the second objective was to establish an 
EQ-5D-3L value set using time trade-off (TTO) values directly measured from the 
general Singaporean population.  
 
The impact of using different sources (i.e. patient and general population) of HSUs is 
important, as for some diseases, the difference in HSU values do exist and may have 
significant impact on the CUA of health interventions (Sackett and Torrance, 1978; 
Llewellyn-Thomas et al, 1982; Boyd et al, 1990; Hurst et al, 1994). Whether the 
divergence in patients and general population HSU values exists and what‟s the 
impact of the divergence need to be assessed for different clinical conditions. Thus, 
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the third objective of this project was to compare the utility values for EQ-5D-3L 
health states between type 2 diabetes mellitus (T2DM) patients and the general 
population in Singapore.  
 
Although research on generating HSU values has grown considerably, there is still a 
lack of valid approaches in many situations. For example, the data collected by 
psychometric instruments which are designed to reflect individuals‟ health status but 
not their preferences for health states cannot be directly used to calculate QALYs. In 
such situations, HSU values need to be obtained through the use of mapping that 
converts the non-preference-based data into preference scores (Brazier et al, 2010). 
Hence, the fourth objective of this project was to develop and test functions for 
predicting the preference-based SF-6D36 index scores from the SF-8 health survey 
(Ware et al, 2001).  
 
Selecting the most appropriate preference-based instrument is important as different 
instruments appear to yield different HSU values for the same health profiles. Generic 
preference-based instruments such as EQ-5D-3L (Dolan, 1997), SF-6D12 (Brazier and 
Roberts, 2004), SF-6D36 (Brazier et al, 2002), and HUI2 and HUI3 (Feeny et al, 1995; 
Torrance et al, 1995) differ significantly in various aspects. Thus, the fifth objective of 
this project was to compare the discriminative power of the SF-6D index scores 
derived from the SF-36 (SF-6D36) and SF-12 (SF-6D12) in the general population. 
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5. Summary of Studies  
The subsequent five chapters are devoted to studies used to address the above five 




 chapter reports a study of comparing the preference values for EQ-5D-5L 
health states between Singapore and mainland Chinese. In this study, the preference 
values for 10 selected EQ-5D-5L health states were elicited using TTO method from a 
convenience sample of Singaporeans  and a convenience sample of mainland 
Chinese in Beijing (China). The difference in TTO values between Singaporeans 
mainland Chinese and three subgroups of Singaporeans (i.e. English-speaking 
Chinese [EC], Chinese-speaking Chinese [CC], and non-Chinese [NC]) was analyzed 




 chapter reports a study of exploring the impact of diabetes on HSUs, using 
data collected from a consecutive sample of outpatients with T2DM in the National 
University Hospital (NUH). T2DM patients‟ utility values for EQ-5D-3L health states 
were compared with values from a general Singapore population sample also using 




 chapter reports a valuation study of establishing the Singapore EQ-5D-3L 
value set. In this study, the values of 80 EQ-5D-3L health states were directly elicited 
from a general Singaporean population sample using a TTO method. Various linear 
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regression models and model specifications were examined to assess their goodness 
of fit to the data, at both aggregate and individual levels, and ability to predict the 




 chapter reports a mapping study of developing a function for yielding the 
preference-based SF-6D36 index score from the SF-8 health survey, using data 
collected in a population health survey in which respondents (n=7,529) completed 
both the SF-36 and the SF-8 questionnaires. Various OLS models were assessed for 
their performance in predicting the SF-6D36 score from the SF-8 at both the individual 




chapter reports a study comparing the discriminative power of the SF-6D 
index score derived from the SF-36 (SF-6D36) and SF-12 (SF-6D12) in the general 
population, using data from a sample of the general US adult population. The 
discriminative power of the SF-6D36 and SF-6D12 were compared using F-statistic and 
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Chapter Two - Do Chinese have similar health-state 




Given the relatively rare resources and rapidly rising costs of health services and 
technologies, cost-utility analysis (CUA) comparing the costs of a service or 
technology with its benefits from the societal perspective is increasingly used for 
setting priorities (Bloom, 2004). In CUA, the benefits are measured in terms of 
quality-adjusted life-years (QALYs) that combines both the quality and quantity of 
life. In order to obtain the quality-of-life weights for calculating QALYs, researchers 
need to measure the general public‟s preferences for the relevant health outcomes 
(Gold et al, 1996). The preference values of health outcomes are measured on an 
interval scale on which 1 is full health, 0 is death, and negative values correspond to 
health states regarded as worse than death (Drummond et al, 2005).  
 
Preference-based instruments such as the EQ-5D-3L (Dolan, 1997), the health utilities 
index (HUI) (Feeny et al, 2002) and the short form 6-dimensions (SF-6D36) (Brazier, 
2002) are designed to measure the value of health services or technologies to the 
society. Such instruments comprise a questionnaire for describing individuals‟ health 
and a set of values indicating the value of the health states it describes to the general 
public. The values are estimated based on empirically measured health-state 
preferences from a general population sample using valuation techniques such as the 
Chapter 2. Comparison of health-state utilities  Wang, Pei 
29 
 
time trade-off (TTO) (Torranc et al, 1972) and standard gamble (SG) (Torrance, 
1986).  
 
Whether the general populations in different countries have different health-state 
preferences is an important issue in economic evaluation of health services and 
technologies. If the preferences of different populations are systematically different 
and could lead to different CUA results, it is necessary to use local preference value 
sets in CUA; otherwise, the preferences estimated from one particular population 
could be applied to other populations, and the resources and time spent for developing 
local preference value sets can be saved.   
 
To date, a number of studies compared health-state preferences across different 
populations (Drummond et al, 2005; Badia et al, 2001; Luo et al, 2007; Wang et al, 
2002; Norman et al, 2009; Tsuchiya et al, 2002; Johnson et al, 2005). However, the 
findings are mixed. Some studies suggested that the differences in health-state 
preferences across populations are either absent or negligible (Drummond et al, 2005). 
Other studies indicated that health-state preferences differ significantly among 
different populations and may influence the results of CUA. For example, a recent 
review of the TTO values for EQ-5D-3L health states found that compared to the 
range of UK TTO values, the ranges of Japan and US TTO values are narrower, which 
could lead to less cost-effectiveness in CUA (Norman et al, 2009). It should be noted 
that many of those studies have the limitation of using pooled data from independent 
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studies in which different valuation procedures were used. It has been well 
demonstrated that different variants of the prevailing valuation methods such as SG 
and TTO lead to systematically different health-state values (Dolan et al, 1996).  
 
We are particularly interested in the issue of whether Chinese in different regions have 
similar health-state preferences given the fact that Chinese people mainly live in 
several geographically distinct areas (e.g. mainland China, Singapore, Hong Kong, 
Tai Wan, and Macau) and there is no study comparing the preference values among 
Chinese populations in different regions. For this purpose, we conducted a 
head-to-head comparison of the TTO preference values for EQ-5D-5L health states 
elicited from mainland Chinese and Singaporean Chinese who form 74.2% of the 




The data used in this study was from the multinational pilot valuation study of the 
EQ-5D-5L health states (Oppe et al, 2012). This valuation study collected data from 8 
general population samples, each from a different country. Investigators in each study 
site collected data using a standard procedure to answer a common primary research 
question, although they also collected additional data using slightly different 
procedures to address various secondary research questions. Since the current study 
only used data from mainland China and Singapore, study designs used in the two 
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countries were described below.  
 
Sampling and recruitment  
The study samples in mainland China and Singapore were drawn in a similar way. In 
both sites, the sampling frame was on a large cohort of general population members 
maintained by a commercial research company. Members from the Singapore cohort 
were from all over Singapore and had good computer skills since they participated in 
on-line surveys periodically; members of the Chinese cohort mainly resided in Beijing, 
the capital of China where many residents were immigrated from other regions of 
China.  
 
In both study sites, members in the sampling frames were randomly selected and 
personally invited through telephone by the research companies. Stratified random 
sampling was conducted in the recruitment process in order to achieve samples with 
balanced distributions of gender and age groups. Participants‟ eligibility was checked 
twice during the recruitment and on the day of survey using the following criteria: 1) 
aged 18 years or above; 2) literate and able to read text from a computer screen; 3) 
able to use a mouse and Internet Explorer to surf the internet; 4) able to give informed 
consent. Literacy was defined as able to read English or Chinese newspapers and to 
converse fluently in either language.  
 
 




Consenting participants were invited in small groups to a computer room to complete 
a survey in the manner of computer-assisted self interviewing (CASI). Each 
participant was assigned to a computer on which the EQ-VT program was run to 
administer the survey questions. Participants were asked to independently complete 
the survey after a group demonstration of how the interview software program works. 
Investigators were around the room to provide assistance if any participant 
encountered any difficulties. Participants received a monetary incentive worth 
approximately 15 Euros on completion of the survey. In accordance to a standard 
study protocol, the target sample size was 400 in both study sites.  
 
EQ-VT 
The EQ-VT is a software package developed by the EuroQol Group 
(www.euroqol.org) for collecting raw valuation data of the EQ-5D-5L health states. It 
was designed for use in the mode of CASI. The Chinese version of EQ-VT was 
translated by a professional translation company from English into Chinese and tested 
extensively for technical issues and understandability in the target populations.  
 
The survey was programmed into four sections. The questions in the first section were 
for warm-up purpose. Participants in the section were asked to rate their own health 
status using the EQ-5D-5L questionnaire and provide background information on 
their age and gender. The EQ-5D-5L questionnaire contains two parts: the EQ-5D-5L 
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classification system and the EQ visual analogue scale (EQ-VAS). The classification 
system is a new version of the EQ-5D-3L, which has the same 5 domains as the 
EQ-5D-3L, but is with 5 descriptive levels (EuroQol Group, 2013). The EQ-VAS can 
record participants‟ own health on a vertical visual analogue. The second section 
collected valuation data for 10 selected pairs of different EQ-5D-5L health states. The 
third section included 5 TTO tasks for measuring preference values of 5 EQ-5D-5L 
health states. The questions in the last section collected participants‟ feedback and 
comments on the survey questions.  
 
The TTO tasks in the third section were presented using either standard or 
experimental arms. In both sites, participants were randomized to one arm and one 
block of health states (n=5). The TTO tasks in the standard arm were the same for the 
two sites but have some differences in the experimental arm which was reported 
elsewhere (Luo et al, 2013). Only the data collected from the standard arm was used 
in the current study.  
 
In the standard arm, each state was valued using a series of questions each asking  
the participant‟s preference between two hypothetical lives: living in full health for 10 
years followed by 5 years in the state valued and then die (Life A) and living x years 
(0<=x<=15) in full health and then die (Life B). For each question, the participant‟s 
response could be Life A, Life B, or A & B are about the same. If the response was 
life A or Life B, a new question with a different x value would be presented to the 
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participant. The questioning would stop when the response was „A & B are about the 
same‟. In this case, the current valuation task would end and a new task for a different 
health state would start. How the x values changed was reported elsewhere (Oppe et 
al, 2012). Briefly, the first two values of x were 15 and 10 years. The third value for x 
was 12.5 (or 5) years if the answer to the second question was Life A (or Life B). The 
x values in subsequent questions varied with a unit from 3 months to 1 year 
depending on participants‟ responses.  
 
Since limited numbers of x values were programmed in the EQ-VT, some participants 
may not answer „A & B are about the same‟ for some health states at any provided x 
values. In such cases, the available x value closest to the indifference point between 
the two lives would be used as the indifference point.  
 
Health states valued 
The health states valued in the study were defined by the EQ-5D-5L health-state 
classification system. The classification system comprises 5 domains (i.e. mobility, 
self-care, usual activities, pain/discomfort, and anxiety/depression), and each domain 
has 5 functional levels including no problem (level 1), slight problems (level 2), 
moderate problems (level 3), severe problems (level 4), and extreme problems(level 
5)
21
. Each EQ-5D-5L state can be expressed by a 5-digit number. For example, 12345 
represents no problems in mobility, slight problems in self-care, moderate problems in 
usual activities, severe problems in pain or discomfort, and extreme problems in 
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anxiety or depression. The 10 EQ-5D-5L states selected by the EQ-VT spread over 
various severities, including 12112, 52221, 33133, 44113, and 53555 in one block, 
and 21111, 11221, 52324, 55523, and 11145 in the other block. The EQ-5D-5L health 
states were divided into two categories: states with and without severe health 
problems. Two or three states were randomly selected from each category to construct 
a block of 5 states.  
 
Data Analysis  
Participants were excluded if they valued all states the same, which was regarded as 
not really understand the valuation tasks; non-Chinese participants from Singapore 
were also excluded. In addition, TTO values were excluded if they only spend 1 
second on the task, which was considered as unreliable. The characteristics of 
mainland Chinese and Singaporean Chinese participants were compared using 
Chi-square tests or Fisher‟s exact tests for categorical variables and two-sample t-tests 
for continuous variables.  
 
The TTO value for each EQ-5D-5L health state valued was calculated as U= (T-10)/5, 
in which U is the TTO value and T (0<=T<=15 years) is the time at which 
indifference was reached. The possible range of the TTO values was therefore from -2 
(T=0) to 1 (T=15).  
 
Data collected from the two populations were pooled for a series of regression 
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analysis. First, the TTO values for all the 10 health states were analyzed using a linear 
regression model. Second, the TTO values for states with mild or moderate problems 
(i.e. 11221, 12112, 21111, and 33133), states with severe or extreme problems (i.e. 
44113, 11145, 52324, 53555, and 55523) and each of the 10 health states were 
investigated using separate linear regression models. Third, whether mainland 
Chinese and Singaporean Chinese have different tendency to rate the health states as 
worse than death (i.e. TTO values<0) was investigated using logistic regression model. 
In all models, the TTO value was regressed on the source of the value (Singaporean 
Chinese or mainland Chinese) with and without the adjustment of other factors. The 
factors adjusted for included age, gender, TTO block, and self-reported health 
problems in EQ-5D-5L domains. All adjusted factors were coded into dummy 
variables. For the health-state characteristics, five dummy variables were generated to 
specify the existence of any health problems in each of the domains of a health state. 
The random effects were built into the models to adjust for individual cluster of data 
in which participants gave multiple TTO values.  
 
Results 
A total of 210 participants completed the valuation survey using standard visual aids 
in the mainland China study. After excluding 16 participants who gave same TTO 
values for all the 5 health states and 6 valuation tasks that were completed within 1 
second, 964 TTO values derived from 194 participants were used in this analysis. The 
mean age of the participants was 36.5 years old, with male being 50.0%. The majority 
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of them did not experience any problems in EQ-5D health domains on the day of the 
survey (58.2%) (Table 1). 
 
In the Singapore study, 2 Singaporean Chinese participants were excluded since they 
valued all health states same and 50 non-Chinese participants were excluded. After 
that, 145 participants with 725 observations of TTO values were included in the 
analysis. The mean age of the participants was 37.6 years old, with male being 53.1%. 
The majority of them was English-speaking (62.8 %), and many of them did not 
experience any problems in EQ-5D health domains on the day of the survey (48.7%) 
(Table 1).  
 
Participants from the two populations differed significantly in some aspects. For 
example, mainland China participants reported better overall health, and were less 
likely to experience health problems in EQ-5D domains (Table 2.1).  
Table 2.1 Characteristics of participants 







Gender   0.3525 
  Male 97 (50.0) 77 (53.1)  
  Female 97 (50.0) 68 (46.9)  
Age group, year   0.4663 
  18-44 years 144 (74.2) 108 (71.7)  
  >44 years 50 (25.8) 41 (28.3)  
Interview language   <0.0001 
  Chinese 194 (100) 54 (37.2)  
  English 0 (0) 91 (62.8)  
Mobility   0.0015 
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  No problems 191 (98.4) 139 (95.9)  
  With problems 3 (1.6) 6 (4.1)  
Self-care   0.1958 
  No problems 192 (99.0) 142 (97.9)  
  With problems 2 (1.0) 3 (2.1)  
Usual activity   0.0919 
  No problems 189 (97.4) 138 (95.2)  
  With problems 5 (2.6) 7 (4.8)  
Pain/discomfort   <0.0001 
  No problems 143 (73.7) 86 (59.3)  
  With problems 51 (26.3) 59 (40.7)  
Anxiety/depression   0.3689 
  No problems 138 (71.1) 108 (74.5)  
  With problems 56 (28.9) 37 (25.5)  
VAS, mean (SD) 89.5 (9.1) 84.6 (10.1) <0.0001 
TTO block   0.2129 
  1 97 (50.0) 65 (44.8)  
  2 97 (50.0) 80 (55.2)  
Chi-square tests or Fisher's exacts test for categorical variables and two sample t-tests 
for continuous variables; SD – standard deviation. 
 
All 10 EQ-5D-5L health states considered, the mean TTO value was 0.18 for 
Singaporean Chinese and 0.35 for mainland Chinese, with the difference (95% 
confidence interval [95%CI]) being 0.17 (0.07, 0.28); the proportion of TTO values < 
0 for Singaporean Chinese (21.2%) was higher than that for mainland Chinese 
(18.8%), with the odds ratio (95%CI) of giving a negative value for Singapore versus 
mainland China being 1.41 (0.89, 2.24). The mean TTO values of mainland Chinese 
and Singaporean Chinese were similar when the values for states with mild or 
moderate problems were considered; while mainland Chinese had substantially higher 
TTO values for states with severe or extreme health problems (Table 2.2. The mean 
difference (95%CI) between the two populations was 0.04 (-0.07, 0.15) for the former, 
and 0.32 (0.19, 0.44) for the latter. The magnitude of these differences remained 
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similar after adjusting for other variables (Table 2.2).  
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Table 2.2 Comparison of TTO values between Mainland Chinese and Singaporean Chinese 
 mainland Chinese Singaporean Chinese Difference between mainland Chinese and 
Singaporean Chinese* 
Mean (SD) Mean (SD) Unadjusted (95%CI) Adjusted(95%CI)
†
 
All health states 0.35 (0.60) 0.18 (0.75) -0.17 (-0.28, -0.07) -0.16 (-0.27, -0.05) 
Health states with 
mild or moderate 
problems 
0.45 (0.55) 0.49 (0.61) 0.04 (-0.07, 0.15) 0.04(-0.07, 0.15) 
Health states with 
severe or extreme 
problems 
0.28 (0.61) -0.04 (0.76) -0.32 (-0.44, -0.19) -0.30 (-0.42, -0.17) 
 
















CI: confidence interval; SD: standard deviation; OR: odds ratio. 
*Reference group is mainland Chinese and the random effect was used in the comparison analyses with and without adjustment 
† 
Random effect linear regression model, in which age group, gender, TTO block, and self-reported health problems in EQ-5D-5L health 
domains 
‡ 
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The mean values of individual health states varied from -0.21 (for 53555) to 0.57 (for 
12112) for Singaporean Chinese and from 0.19 (for 53555) to 0.50 (for 21111) for 
mainland Chinese (Figure 2.1), with the range being 0.78 and 0.31 for Singaporean 
Chinese and mainland Chinese, respectively. Difference in the mean TTO values was 
less than 0.10 for four states in which only slightly or moderate problems are present 
in one or more of the EQ-5D health dimensions (i.e. 11221, 12112, 21111, and 33133). 
On the other hand, the difference ranged from 0.19 to 0.40 for the remaining six states 
in which at least one health dimension is described as having severe or extreme 
problems, with statistical significance observed in four of the states where the largest 
differences occurred (Figure 2.1).   
   
Figure 2.1 Mean TTO values for each of the 10 EQ-5D-5L health states between 
Mainland Chinese and Singaporean Chinese 
 
* Difference in TTO values between mainland Chinese and Singaporean Chinese is 
statistically significant with adjustment of age, gender, TTO block, and self-reported 
health problems in EQ-5D-5L health domains 
 
 





































    11221   12112   21111   33133    44113*   11145   52221*   52324   53555*  




To the best our knowledge, this was the first study comparing directly measured 
health-state preference values between two Chinese populations. Previous studies 
compared between different Western populations (Badia et al, 2001; Johnson et al, 
2005; Johnson et al, 2000) or between an Asian population and a Western population 
(Tsuchiya et al, 2002). Moreover, those studies used data collected from independent 
studies conducted in different times by different investigators. In contrast, data used in 
our study was collected by the same investigators using exactly the same study 
protocol, thus ruling out the effects of some unobservable confounders in the 
comparison. Hence, our study provides important information on the similarity or 
difference in health-state preferences among Chinese populations because it has 
shown differences in health state valuation in two Chinese populations using exactly 
the same study design and protocol.  
 
We found that Singaporean Chinese valued EQ-5D-5L health states lower, that they 
were more likely to rate a health state as worse than death, and more importantly, that 
they valued states with severe or extreme problems as much more undesirable than 
mainland Chinese. This result suggests that the health benefit gained from a transition 
from a severe health state to a mild health is much greater to Singaporean Chinese 
than to mainland Chinese. For example, according to our study, the gain from 
transition between 11145 and 12112 would be 0.43 and 0.18 to Singaporean Chinese 
and mainland Chinese, respectively. This means a health service or technology which 
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can achieve such an improvement in health would be considered much more 
cost-effective to Singaporean Chinese than in mainland Chinese, if the associated 
costs are similar. Therefore, an important implication of our study is that a local value 
set for EQ-5D-5L health states should be used in cost-utility analysis to Singaporean 
Chinese since using the EQ-5D-5L values of mainland Chinese could underestimate 
the value of health technologies of investigation. Hence, our study supports the 
development of local EQ-5D-5L preference value sets in these two Chinese regions to 
inform decision making for health resource allocation.   
 
The difference in TTO values between the two countries should be due to the fact that 
poor life is more undesirable than short life to Singaporean Chinese compared to 
mainland Chinese. This may be attributed to two reasons: medical costs and attitude 
towards death and longevity. First, medical costs are mainly borne by individuals and 
their immediate family members in Singapore. As a result, Singaporeans including 
Singaporean Chinese may be more willing to give up life years in order to reduce 
financial burden due to poor health. A recent study in Singapore found that cancer 
patients would not choose to use better but more expensive treatment if they had to 
pay for the treatment (BMJ Group Blogs, 2013). In contrast, the majority of health 
expenses can be reimbursed for urban residents (e.g. residents in Beijing) in mainland 
China (World Health Organization, 2013). It should be noted that respondents to TTO 
or other health-state valuation questions should not consider the economic 
consequences of the health problems to be valued. However, it would be difficult for 
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respondents to follow exactly such instructions if in reality health services are not free. 
Second, most mainland Chinese prefer to have a longer life. In a recent study, 50.3% 
of mainland Chinese endorsed that: “a living dog is better than a dead lion” and that 
72.8% of participants reported that they do not believe life after death. Singaporeans 
might be less afraid of death because 83% of the population believed in certain 
religion (Singapore Department of Statistics, 2013) as compared to about 20% in 
mainland China (BBC New, 2013). Nevertheless, those reasons are speculative, future 
studies should further explore the impact of death and longevity attitudes on 
health-state valuations.  
 
There were two limitations in this study. First, in both countries, the stratified random 
sampling method was used and all participants recruited possessed some levels of 
computer skills. Moreover, mainland Chinese participants were mainly from Beijing. 
Hence, the generalizability of our findings may be limited. Second, the TTO valuation 
tasks were self-administered although assistance would be provided on participants‟ 
request. As a result, some participants might not fully understand the tasks and gave 
erroneous responses (Oppe et al, 2012), which may reduce the statistical power and 
even the validity of our findings. Due to these limitations, the finding of our study 
should be treated with caution. 
  
In conclusion, the TTO values of EQ-5D-5L health states differ between mainland 
Chinese and Singaporean Chinese, which could lead to different CUA results if one 
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population‟s preferences are used to the other population. Hence, local EQ-5D-5L 




Chapter 3. Impact of diabetes on health-state utilities  Wang, Pei 
46 
 
Chapter Three - The impact of diabetes on health-state 
utilities 
Introduction 
Utility of health technologies is usually evaluated using health-state utilities elicited 
from general or patient populations. While there seems to be a consensus that patients 
should be the source of utility values in the context of clinical decision making (Gold  
et al, 1996; Dobrez et al, 2007; Revicki et al, 2011), whose values should be used in 
analysis intended to inform allocation of societal health resources has long been 
debated (Dolan, 1999(a); Dolan, 1999(b); Ulber et al, 2003; Ulber et al, 2000; Brazier 
et al, 2005; Gandjour, 2010). The main argument for using the values elicited from the 
general population is that members of the general population are the payers and 
potential users of health technologies and services. On the other hand, Gandjour 
argued that only patient utilities have a theoretical foundation in preference-utilitarian 
theory and welfare economics (2010). The issue of whose values to use is based on 
the assumption that the health-state preferences of the general population and patient 
populations differ. Indeed, some studies supported this assumption (Froberg and Kane, 
1989; Boyd et al, 1990; Llewellyn-Thomas et al, 1982; Zethraeus et al, 1999). For 
example, it was found that patients who have received colostomies rate the utility of 
alive with a stoma as much higher than those who do not experience colostomies
 
(Boyd et al, 1990). However, some other studies (Pickard et al, 2013; 
Llewellyn-Thomas et al, 1984; Balaban et al, 1986; Dolders et al, 2006) including a 
meta-analysis (Dolders et al, 2006) found no or minimal difference in health-state 
utilities from general and patient populations, suggesting that the source of utility 
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values may not be crucial.  
 
The EQ-5D-3L is a standardized instrument that is widely used to measure the utility 
of health technologies for calculating quality-adjusted life years in economic 
evaluations (Dolan, 1997). It defines a total of 243 unique health states whose utility 
values are determined using the time trade-off (TTO) or visual analog scale (VAS) 
methods from general population samples. While the EQ-5D-3L has been 
recommended by many health technology assessment agencies for use in economic 
evaluations, it is not known whether its value sets based on the general populations‟ 
health preferences are suitable for clinical decision making where patients‟ 
preferences are most appropriate. The key question is: are the values of the EQ-5D-3L 
health states the same to the general population and the patients of interest? If they are 
the same or the difference is negligible, the EQ-5D-3L and its current value sets can 
be used to inform clinical decision making as well; otherwise, the values of the 
EQ-5D-3L health states from patients of interest should be used. A few studies 
compared the values of EQ-5D-3L health states to healthy individuals and unhealthy 
individuals showed mixed results. Pickard et al suggested that chronic conditions have 
trivial impact on utility values (2013); others suggested that patient and the general 
population have significantly different utility values (Suarez and Conner, 2001; Badia 
et al, 1996; Badia et al, 1998, De Wit et al, 2000; Mann et al, 2009).   
 
The aims of our study was to compare the TTO values of EQ-5D-3L health states 
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directly elicited from patients with type 2 diabetes mellitus (T2DM) and the general 
population to determine whether the values differed, and if so, how they differed.  
 
Methods  
Study participants  
Consecutive outpatients with T2DM were approached and enrolled from the diabetes 
clinic of the National University Hospital from May to December 2012.The inclusion 
criteria are: 1) a diagnosis of type 2 diabetes mellitus; 2) Singapore citizens/Singapore 
permanent residents aged 21years or above; 3) ability to read and converse in English. 
Consenting T2DM patients were interviewed by a trained interviewer to value 5 
EQ-5D-3L health states in the clinic after their routine consultations. 
 
A valuation study of the EQ-5D-3L health states in Singapore provided valuation data 
for EQ-5D-3L health states from a sample of the general Singaporean population. The 
sampling and recruitment procedures used were reported in detail in Chapter 4. 
Briefly, a random sample of non-institutional adult Singaporean residents were 
recruited and interviewed face-to-face in their homes by a trained interviewer. Each 
participant was asked to value a total of 10 EQ-5D-3L health states. Only the 
participants who valued the same EQ-5D-3L health states as T2DM patients did and 








An identical interview protocol was used to survey T2DM patients and in the general 
population study to measure the utilities of the EQ-5D-3L health states. The survey 
started with an example TTO task in which the interviewer demonstrated how the 
TTO tasks would be conducted using a time board and cards. Five states were 
presented to T2DM patients in a random order for valuation T2DM patients‟ own 
health status and demographic characteristics were assessed after the TTO valuation 
tasks.  
In TTO tasks, each state was valued by asking a participant to state preferences for 11 
questions each asking the participant‟s preference for two hypothetical lives: (a) living 
in the health state for 10 years and then die and (b) living in full health for x years and 
then die. The x values were integers ranging from 0 to 10, with one integer 
corresponding to one question. For each question, the response could be (a), (b), or 
equal preference (no preference). As previous studies found that TTO values are 
affected by the starting point of x values (Samuelsen et al, 2012), two starting points, 
0 and 10 years, were used in the valuation tasks and were randomly assigned to each 
participant in our study. For each health state, half of the T2DM patients started with a 
question asking them to compare 0 years of full health (i.e. immediate death) to10 
years of life in the health state and the length of full health in subsequent questions 
was increased to 10 years by a step of 1 year (i.e. the bottom-up sequence); the other 
half of the T2DM patients started with comparing 10 years of full heath to10 years of 
life in the health state and then the length of full health was decreased to 0 years with 
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a step of 1 years (i.e. the top-down sequence).  
 If a T2DM patient preferred (b) when the x value was 0 (i.e. immediate death), 
another 11 questions would be given to the respondents for stating preferences, each 
question asking respondents‟ preference of two options: (a) living in full health for 10 
years followed by 10 years in the health state and then die and (b) living in full health 
for y years and then die. The y values were also integers ranging from 0 to 10 and the 
values varied from 10 to 0 in all interviews. A time board and health-state cards were 
used as visual aids to help respondents comprehend the different life scenarios.  
 
Both T2DM patients and participants from the general population received a gift 
voucher worth $20 on completion of the survey.  
 
Health states valued 
The health states valued in this study was defined by the EQ-5D-3L classification 
system which comprises 5 domains (i.e. mobility, self-care, usual activities, pain or 
discomfort, and anxiety or depression), with each domain having 3 functional levels: 
„no problems‟ (level 1); „some problems‟ (level 2); and „extreme problems‟ (level 3). 
EQ-5D-3L health states can be expressed using a five-digit code, with each digit 
representing the functional level of one domain. For example, a state in which a 
person has no problems in mobility and self-care, moderate problems in usual 
activities, moderate pain or discomfort, and extreme anxiety or depression can be 
coded as 11223. In this study, 3 mild (11112, 21112, and 21122), 4 severe (11223, 
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23221, 21231, and 23211), and 3 very severe (23332, 32322, and 33333) health states 
were selected to represent various severities. As valuing all 10 health states might be 
too burdensome to T2DM patients, we divided the 10 states into two blocks: 11112, 
21112, 21231, 23221, and 32322 in one block; and 21122, 11223, 23211, 23332, and 
33333 in the other block and randomly assigned each T2DM patient to value one 
block of health states. The EQ-5D-3L health states were divided into three categories: 
mild, moderate, and severe. One or two states were randomly selected from each 
category to construct a block of 5 states.  
 
Data analysis  
The TTO value for each health state was calculated for each participant who valued 
that health state. For health state considered as better than death, the TTO value was 
x*/10, in which x* is the x value at which equal preference was stated. If there were 
multiple x values, x* was the mean of the values; if there was no value at which equal 
preference was stated, x* was mean of the maximum value at which option a was 
preferred and the minimum value at which option b was preferred. For example, if at 
0 to 5 years option a is preferred and at 6 to 10 years option b is preferred, the TTO 
value of the health state would be [(5+6)/2]/10=0.55. Similarly, the TTO value of a 
health state considered as worse than death is given by (y*-10)/10. Poor data quality 
was considered if a T2DM patient (or a participant from the general population) rated 
all 5 (10) health states as having the same value or worse than death. Data of poor 
quality was excluded from further analysis.   




Data collected from T2DM patients and the general population sample was pooled for 
analysis. The characteristics of the two samples were compared using Chi-square 
tests. 
Separate linear regression models were used to investigate the difference in TTO 
values of all health states, mild health states (i.e. 11112, 21112, and 21122), severe 
health problems (i.e. 11223, 23221, 21231, 23211, 23332, 32322, and 33333), and 
each of the health states between T2DM patients and the general population sample. 
In all models, the TTO value was regressed on the source of the value (T2DM patients 
or general population) with and without the adjustment of other factors. The factors 
adjusted for included age, gender, race, education, as well as the characteristics of the 
10 EQ-5D-3L health states being valued whenever appropriate. All factors were coded 
into dummy variables and the random effects estimator was used in the models 
whenever appropriate to account for individual clustering of data. 
 
Results 
A total of 120 T2DM patients were recruited and interviewed in the study. After 
excluding patients whose TTO values were either the same (n=2) or negative for all 
the 5 health states they valued (n=9), 109 T2DM patients were used for comparison 
analysis. Fifty-two participants without DM in the general population study valued the 
same health states valued by the T2DM patients. After excluding 4 participants 
valuing all states as worse than death and 2 participants rating all 10 states the same, 
46 participants were included in the analysis. Compared to the general population, 
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T2DM patients were more likely to be male, elder, non-Chinese, and better educated 
(Table 3.1).  
 
 
Table 3.1 Characteristics of participants  
 N (%) P value 
T2DM patients General population   
Gender   0.0029 
  Male 62 (56.9) 23 (50.0)  
  Female 47 (43.1) 23 (50.0)  
Age group, years    <0.0001 
  21-60 years 71 (65.1) 35 (76.1)  
  >60 years 38 (34.9) 11 (23.9)  
Education level   0.0007 
  College and higher 21 (19.3) 6 (13.0)  
  Middle school and 
lower 
88 (80.7) 40 (87.0)  
Race    <0.0001 
Chinese 54 (49.5) 28 (60.9)  
non-Chinese  55 (50.5) 18 (39.1)  
HbA1c level      
 HbA1c <6.5% 16 (14.7)   
 HbA1c ≥6.5% 87 (85.3)   
Chronic conditions 
other than diabetes  
   
<0.0001 
  Yes 40 (36.7) 11 (23.9)  
  No 69 (63.3) 35 (76.1)  
T2DM: type 2 diabetes mellitus. 
 
All 10 health states considered, the mean TTO value was 0.04 and -0.02 for the 
T2DM patients and the general population sample, respectively (p=0.1643). After 
adjusting for, however, T2DM patients‟ TTO value was 0.02 point lower than the 
general population sample (p=0.6527). With and without adjustment of other 
variables, the mean TTO value of the general population sample was significantly 
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lower than that of T2DM patients for mild health states. The mean difference (95% 
confidence interval [95%CI]) between the general population sample and T2DM 
patients was -0.15 (-0.24, -0.06) before adjustment and -0.13 (-0.25, -0.02) after 
adjustment. On the other hand, with and without adjustment, T2DM patients and the 
general population sample had similar mean TTO values for severe health states 
(Table 3.2). Hence, the difference in the means was greater for the T2DM patients 
than the general population sample.  
Table 3.2 TTO values between T2DM patients and the general population 
T2DM: type 2 diabetes mellitus; SD: standard deviation; CI: confidence interval; OR: 
odds ratio. 
* Reference group is T2DM patients and the random effect was used in the 
comparison analyses with and without adjustment 
† 
Random effect linear regression model, in which age, gender, education, ethnicity, 
and the 10 EQ-5D-3L health states are adjusted  
‡ 
Adjusted for age group, gender, education, and ethnicity only   
 
The mean values of individual health states varied from -0.75 (for 33333) to 0.76 (for 
11112) for T2DM patients and from -0.62 (for 33333) to 0.61 (for 11112) for the 
general population (Figure 3.2), with the range being 1.51 and1.23 for T2DM patients 
and the general population sample, respectively. With and without adjustment, T2DM 





Difference between T2DM patients and 
general population* 
Mean (SD) Mean (SD) Unadjusted (95%CI) Adjusted(95%CI) 
All health states
†
 0.04 (0.74) -0.02 (0.75) -0.06 (-0.16, 0.03) 0.02 (-0.12, 0.15) 
     




0.64 (0.31) 0.48 (0.50) -0.15 (-0.24, -0.06) -0.13 (-0.25, -0.02) 




-0.24 (0.73) -0.24 (0.71) 0.001 (-0.11, 0.11) 0.02 (-0.16, 0.19) 
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hand, there was no systematic difference in the mean values between T2DM patients 




Figure 3.2 Mean TTO values for each of the 10 EQ-5D-3L health states between 
T2DM patients and the general population 
 
*Difference in TTO values between T2DM patients and the general population is 
statistically significant with adjustment of age, gender, education, and ethnicity 
 
Discussion  
We found that the values of EQ-5D-3L states with mild health problems to T2DM 
patients were higher than to the general population, although the EQ-5D-3L states 
with severe health problems values were similarly undesirable to these two 
populations and as a result there was no significant difference between the two 
populations when all EQ-5D-3L health states were considered. Overall similarities in 
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also observed in two previous studies. Pickard et al (2013)found that chronic 
conditions including DM have a negligible impact on TTO valuation in the general 
US population; Suarez Almazor and Conner Spady (2001)found that patients with 
rheumatoid arthritis and the general population have similar TTO values of 2 
EQ-5D-3L health states. Also, our finding that T2DM patients rated mild health states 
better than the general population is consistent with findings from two previous 
studies (Badia et al, 1998; De Wit et al, 2000); however, in both of those studies, 
patients also rated severe EQ-5D-3L states as better than the general population, 
which is inconsistent with the finding about severe EQ-5D-3L health problems in our 
study. The relatively higher or similar EQ-5D-3L values of patients to non-patients 
may be explained by the prospect theory (Treadwell and Lenert, 1999)
.
 According to 
this theory, valuation of hypothetical health states is affected by a rater‟s own health 
status. As a result, a health state is perceived as similarly valuable by patients and 
healthy persons if their health status are similar or if the health state to be valued is far 
better or worse than the health status of patients or non-patients; on the other hand, if 
patients and non-patients have different health status and the health states to be valued 
are not very different from their health status, patients have higher valuation than 
non-patients. It should be noted that the prospect theory is not supported by some 
studies (Feeny and Eng, 2005; Wittenberg et al, 2005). The mixed results from the 
comparisons of patients and general populations may also be due to the different 
valuation methods (i.e. TTO and VAS) or elicitation procedure (e.g. mode of 
administration, search procedures, the use of visual aid, etc) (Dolan et al, 1996; 
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Attema et al, 2013) used in those studies. 
 
Our result suggests that the utility gain associated with a transition from a mild health 
state to a severe health state is greater to T2DM patients than to the general 
population. For example, according to our study, the utility gain from a transition 
between 23332 and 21122 would be 1.08 and 0.94 to T2DM patients and the general 
population, respectively. This means for a health intervention which can achieve such 
an improvement in health is more attractive according to patients‟ preferences than the 
general populations‟ preferences. This implication of our results is consistent with that 
from some previous studies (Lenert et al, 1999; Nord, 1995; Ratcliffe et al, 2007; 
Fujiikee et al, 2011) but inconsistent with that from some other studies (Suarez and 
Conner, 2001; Badia et al, 1996; Badia et al, 1998, De Wit et al, 2000). This is not 
surprising as the relative health-state values elicited from patients and the general 
population or non-patients differed and varied with the severity of the health states to 
be valued. Given these mixed findings, it might be worthwhile to determine the values 
of the EQ-5D-3L health states to patients with a certain condition. Such 
disease-specific EQ-5D-3L value sets, if more sensitive to treatment benefit than the 
conventional value sets, should be used in studies to inform clinical decision making 
for the relevant disease.  
    
Our study has two limitations. First, in the study, each health state was only rated by 
approximately 60 T2DM patients and 50 members of the general population, which 
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may impair the statistical power. Second, the cases and controls were not matched in 
terms of age, gender, education and race. Nevertheless, we adjusted these factors in 
the analysis to account for their influence. Third, we only recruited outpatients with 
T2DM, the findings may not be generalized to inpatients with T2DM who may have 
more severe health problems.   
 
In conclusion, our study indicates that the utility values of mild EQ-5D-3L health 
states are higher to T2DM patients than to the general population and therefore the 
EQ-5D-3L values based on the general population‟s preferences could be insensitive 
and underestimate the effectiveness of health inventions for T2DM. How the values of 
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Quality adjusted life years (QALYs) that combines both quantity and quality of life 
is the outcome measure in cost-utility analysis (CUA) (Torrance, 1986). To calculate 
QALYs, health-state utility that indicates the relative value of health states using a 0 
(being dead) to 1.0 (full health) scale should be used as the quality-of-life weight 
(Torrance, 1986). Health-state utility values elicited from the general population are 
typically used in CUA when the purpose of the analysis is to inform decision making 
in allocation of healthcare resources (Dolan, 1999). Health-state utility can be 
measured using valuation techniques such as time trade-off (TTO) (Torrance et al, 
1972) and standard gamble (SG) (Torrance, 1986). However, those methods are 
difficult to administer and cognitively demanding to respondents. Alternatively, 
preference-based instruments such as the EQ-5D-3L (Dolan, 1997), the health 
utilities index (HUI) (Feeny et al, 2002), and the short form 6-dimensions (SF-6D36) 
(Brazier et al, 2002) can be used to obtain health-state utility values much more 
easily. Those instruments classify a person‟s health into one of a series of predefined 
health states whose utility values are already known. 
 
The preference-based EQ-5D-3L instrument includes two parts: a health-state 
classification system and a value set comprising the utility values of all the health 
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states defined by the classification system. The EQ-5D-3L classification system 
consists of 5 domains: mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression, with each domain being described as three levels: „no problems‟ 
(level 1); „some problems‟ (level 2); and „severe problems‟ (level 3). Each health 
state described by EQ-5D-3L can be coded into a five-digit number. For example, a 
health state in which a person has no problems in mobility and self-care, no pain or 
discomfort, but moderate problems in usual activities and severe anxiety or 
depression can be coded as 11213. This classification system defines a total of 243 
(3
5
) unique health states and can be used as a questionnaire for respondents to 
classify their own health status. The first value set for the EQ-5D-3L health states 
was derived from the general UK population in the measurement and valuation of 
health (MVH) study using a TTO method in 1997 (Dolan, 1997). Country-specific 
EQ-5D-3L value sets were subsequently developed using a similar research protocol 
in many other countries (Shaw et al, 2007; Lee et al, 2009; Tsuchiya et al, 2002; 
Tongsiri and Cairns, 2011; Yusof et al, 2012; Golicki et al, 2010; Jelsma et al, 2002; 
Lamers et al, 2006; Cleemput, 2010; Wittrup-Jensen, 2002). Studies showed that 
utility values of EQ-5D-3L health states differed across countries ( Tongsiri and 
Cairns, 2011; Jelsma et al, 2003; Wittrup-Jensen, 2002; Norman et al, 2009), 
suggesting that each country should develop its own value set for using the 
EQ-5D-3L in economic evaluations of health technologies. 
 
In Singapore, the EQ-5D-3L questionnaire has been psychometrically validated (Luo 
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et al, 2003a; Luo et al, 2003b; Luo et al, 2003c; Luo et al, 2009; Gao et al, 2009) and 
widely used in clinical and epidemiological studies (Abdin et al, 2010; Wang et al, 
2012; Chong et al, 2012; Zhang et al, 2009). However, the values of the EQ-5D-3L 
health states to Singaporeans are not known. As a result, researchers using the 
EQ-5D-3L in Singapore had to use the UK, US, or Japanese value set to acquire 
utility scores (Luo et al, 2003a; Luo et al, 2003b; Luo et al, 2003c; Luo et al, 2009; 
Gao et al, 2009; Abdin et al, 2010; Wang et al, 2012; Chong et al, 2012; Zhang et al, 
2009 ). The aim of this study was therefore to derive a Singapore societal value set 
for EQ-5D-3L health states using the TTO method.  
 
Methods 
Sampling and recruitment 
This study was approved by the National University of Singapore Institutional 
Review Board (NUS-IRB). In the study, we drew a nationally representative sample 
of the non-institutionalized general Singaporean population. We excluded the 
institutionalized population because our purpose was to estimate the general 
population‟s health preferences which are most relevant to decision making in health 
resource allocation (Gold et al, 1996). A three-stage sampling method was used to 
recruit 500 residents aged 21 years and above, with quotas set to achieve similarity 
between the sample and the general adult Singaporean population in age, gender, and 
housing type (an indicator of socio-economic status). The two minority ethnic 
groups (i.e. Malays and Indians) were oversampled and only the English-speaking 
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Singaporeans were recruited. The sampling procedure was as follows. The sampling 
procedure was as follows. First, a total of 20 locations were randomly selected from 
a sampling frame comprising over 9,000 residential locations, covering almost all 
public housing blocks in Singapore. Second, 25 households were recruited from each 
selected location using a systematic sampling method. Third, one resident from each 
consenting household was invited to the study. If the household had more than one 
eligible resident, the first one whom interviewer approached was recruited. Residents 
who were foreign workers or could not speak English were excluded. All 
respondents were interviewed face-to-face in their homes by a trained interviewer. 
Respondents received a gift voucher worth S$20 on completion of the interview.  
 
The valuation interview  
The interview started with an assessment of the respondent‟s health status using the 
EQ-5D-3L questionnaire. This was for familiarizing the respondent with the 
EQ-5D-3L descriptive system. Before proceeding to valuation of the EQ-5D-3L 
health states, the interviewer went through an example TTO task with the respondent 
to make sure the latter understand the questions. The interviewer then showed 10 
EQ-5D-3L health states, one at a time in a random order, to the respondent and 
conducted the valuation tasks as described below. The respondent‟s demographic 
characteristics and feedback on the interview were collected after the completion of 
the valuation tasks.  
In each valuation task, the TTO value of a health state was elicited by asking a 
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respondent to state preferences for 11 pairs of scenarios each comprising two options: 
(a) to live in the health state for 10 years and then die; and (b) to live in full health 
for x years and then die. The values for x were integers ranging from 0 to 10. For 
each pair of the scenarios, the response could be (a), (b), or equal preference (no 
preference). As previous studies found that TTO values are affected by the starting 
point of x values (Samuelsen et al, 2012), two starting points, 0 and 10 years, were 
used in the valuation tasks and were randomly assigned to each participant in our 
study. For each health state, half of the respondents start with a question asking them 
to compare 0 years of full health (i.e. immediate death) with 10 years of life in the 
health state and the length of full health in subsequent questions was increased to 10 
years each time by 1 year (i.e. the bottom-up sequence); the other half of the 
respondents start with 10 years of full heath with 10 years of life in the health state 
and then the length of full health was decreased to 0 years by a step of 1 year (i.e. the 
top-down sequence).  
 
If a respondent‟s preference was (b) when the x value was 0 (i.e. immediate death), 
another 11 pairs of scenarios would be posed to the respondent for stating 
preferences, each pair comprising two options: (a) to live in full health for 10 years 
followed by 10 years in the health state and then die; and (b) to live in full health for 
y years and then die. The values for y were integers ranging from 0 to 10 and the 
values were used in the order from 10 to 0 in all interviews. As in previous 
EQ-5D-3L valuation studies (Dolan, 1997; Shaw et al, 2007), a time board and show 
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cards were used as visual aids to help respondents comprehend the different life 
scenarios.  
 
The health states 
A total of 80 EQ-5D-3L health states were included in the study for valuation. Those 
included state 33333 and 79 states that we selected through reviewing primary 
EQ-5D-3L data collected in past surveys of general and patient populations. Using 
pre-defined definitions, 24, 32, and 24 of the selected health states fell into the 
category of mild, moderate, and severe health states, respectively. Mild states had no 
domain in level 3 and up to three domains in level 2, severe states had at least two 
domains in level 3, and all other states were considered moderate. The 80 health 
states were stratified and randomly distributed into 8 blocks, with each block 
comprising 3 mild, 4 moderate, and 3 severe states (Table 4.1). Arrangements were 
made such that each block of health states were rated by similar number of 
respondents.  
Table 4.1 Health states valued in the study  
Severity Block A Block B Block C Block D Block E Block F Block G Block H 
Mild 21121 21122 12122 11221 21212 12212 12121 11222 
 22112 11112 12221 11211 12111 12211 22121 11122 
 22211 21112 11121 21221 21211 21111 11212 22111 
Moderate 32221 23221 22212 22222 11232 21222 21131 12231 
 11132 21231 13221 23222 22221 21113 12223 12222 
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 11123 11223 21312 21232 22311 11113 22223 11131 
 21223 23211 22321 12232 21322 21321 11213 21311 
Severe 33323 32322 21233 22331 33222 13332 23322 33312 
 22323 23332 12332 23312 33311 13333 33321 11233 
 23232 33333 33331 23333 23311 23323 33332 32332 
 
Statistical analysis  
Calculation of TTO values 
The TTO value of each health state was estimated for each respondent who valued 
that health state as follows. If the health state was considered better than death, the 
value was given by X/10, where X is the x value at which equal preference was 
stated. If there are multiple x values, X is the mean of the values; if there is no value 
at which equal preference was stated, X is mean of the maximum value at which 
option (a) was preferred and the minimum value at which option (b) was preferred. 
For example, if at 0 to 5 years option (a) is preferred and at 6 to 10 years option (b) 
is preferred, the TTO value of the health state would be [(5+6)/2]/10=0.55. Similarly, 
the TTO value of a health state considered as worse than death is given by (Y-10)/10. 
Poor data quality was considered if a respondent rated all 10 health states as having 
the same value or worse than death, or rated only two or fewer health states. Data of 
poor quality was excluded from modeling analysis.   
 
Modeling of TTO values  
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Linear regression models using various functional forms were tested with the TTO 
data. Consistent with previous studies (Dolan, 1997; Shaw et al, 2007), model inputs 
were characteristics of the health states only and disutility (i.e. 1 minus TTO value) 
of the health states was modeled. The functional forms we tested included the 
main-effects, N3, and D1 models. The main-effects model contained 10 dummy 
variables, including M2 and M3 for mobility, S2 and S3 for self-care, U2 and U3 for 
usual activities, P2 and P3 for pain/discomfort, and A2 and A3 for 
anxiety/depression. Since each domain was described using three different levels, 
two dummy variables were needed. The N3 model is the main-effects model with 
addition of a dummy variable N3. The N3 term takes the value of 1 if any domain of 
a health state is in level 3; otherwise the value is 0 (Dolan, 1997). Both the 
main-effects and N3 models were estimated with and without a constant in our study. 
Without the constant, the models assume no disutility for state 11111, which is 
consistent with the expected utility theory and was recommended (Brazier et al, 
2002). The D1 model contains the D1, and I2, I22, I3 and I32 terms in addition to the 
10 main effects (Shaw et al, 2007). The D1 term represents the number of domains at 
level 2 or level 3 minus 1; the I2 term is the number of domains at level 2 minus 1; 
the I3 term is the number of domains at level 3 minus 1; the I22 and the I32 terms 
are squared I2 and I3 terms, respectively. The D1 model does not contain the 
constant term as the D1 term is a pseudo constant term. Hence, a total of 5 different 
functional forms were tested: (1) main effects with a constant; (2) main effects 
without a constant; (3) main effects with a constant and the N3 term; (4) main effects 
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with the N3 term only; and (5) main effects with D1 and related terms.    
 
All functional forms were estimated using the TTO data at both individual and 
aggregate levels. At individual level, the assumption of independence for the 
ordinary-least square (OLS) estimator was violated since each respondent valued 
multiple health states. For this reason the random effects (RE) model and the fixed 
effects (FE) estimators were also used. The Lagrange Multiplier (LM) test (Silvey, 
1959) was used to test the model assumption for OLS versus RE or FE models, and 
the Hausman test (Hausman, 1978) was used to compare the appropriateness of the 
RE and FE models. At aggregate level, the disutility of the 80 health states 
(calculated as 1 minus the mean TTO value) was modeled using the OLS estimator. 
All models were tested for heteroskedasticity using the Breusch-Pagan test (Breusch 
and Pagan, 1979) and normality of residuals using Shaprio-Wilk test (Shapiro and 
Wilk, 1965).  
 
Evaluation of model performance  
Four criteria were used to determine which model had the best performance and 
therefore should be selected to predict the EQ-5D-3L values. Those were, in the 
order of high to low priority, consistency, bias, precision, and parsimony. 
Consistency requires the predictions for measured and unmeasured EQ-5D-3L states 
to be consistent with the utility theory. That means that more severe problems (e.g. 
„extreme pain/discomfort‟) should be associated with more disutility than less severe 
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problems (e.g. „moderate pain/discomfort‟) and that worse health states (e.g. 11133) 
should have lower TTO values than better health states (e.g. 11132). While 
assessment of prediction consistency can be based on the estimated regression 
coefficients for the main-effects and N3 models, it is not straightforward for the D1 
model because of its complex model specification. We therefore compared D1 model 
predicted values for all possible pairs of EQ-5D-3L health states. Prediction bias 
refers to systematically higher or lower predictions than observed values. We were 
particularly concerned about prediction bias for very mild and very severe health 
states. For assessing prediction bias, we examined the overall agreement between 
predicted and observed mean TTO values for the 80 health states using intra-class 
correlation coefficient (ICC) (Fayers and Machin, 2005). We also used the 
Bland-Altman plot (Bland and Altman, 1986) to visually assess the prediction bias in 
different segments of the utility scale. Prediction precision of the models was 
evaluated in terms of mean absolute error (MAE), the numbers of prediction errors 
greater than |0.10| and |0.20|. Lastly, if multiple models performed similarly in 
consistency, bias, and precision, the model using the simplest functional form would 
be preferred (i.e. model parsimony).    
 
In both individual- and aggregate-level modeling analysis, sampling weights were 
applied to the data to reflect the distributions of age, gender, and ethnicity of the 
general adult Singaporean population in 2010 (Department of Statistic Singapore, 
2013). Analyses were performed with SAS 9.2 and STATA 12.0.   




Respondents’ characteristics  
A total of 505 respondents were successfully interviewed, representing a response 
rate of 46.8%. After excluding respondents whose TTO scores were either the same 
(n=2) or negative for all the 10 health states they rated (n=47), data from 456 
respondents was used for modeling analysis. There were no significant differences in 
socio-demographics between excluded and included respondents, and characteristics 
of the included respondents were similar to those of the general adult Singaporean 
population except that by design there was a higher proportion of Malays (13.3%) 
and Indians (17.3%) in our sample (Table 4.2).  
Table 4.2 Socio-demographic statistics of full sample and valuation sample 
compared with Singapore population  
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*comparison between valuation sample and excluded respondents  
Distribution of TTO values 
The 456 respondents generated a total of 4538 TTO values for the 80 health states. 
The distribution of those TTO values was bimodal with mean being 0.09 (standard 
deviation: 0.809). Among the 4538 values, 1363 (29.9%) of them was -1, 138 of 
them was 0 (3.0%), and 167 (3.7%) of them was 1. Overall, there was no statistically 
significant difference in TTO values between participants who started the questions 
from 0 years (mean: 0.036) and those who started the questions from 10 years (mean: 
0.152, p=0.2865). In 47 of the 4538 TTO tasks (1%) completed by 24 respondents, at 
least one indifference response was observed; multiple indifference responses were 
observed in 31 TTO tasks completed by 16 respondents. 
 
Modeling analysis 
Modeling of individual-level data showed that all the seven models fit the data 
reasonably well (Table 4.3). Regression coefficients for the 10 main effects in each 
model were statistically significant and consistent with the utility theory in that more 
severe health problems are associated with higher disutility. For example, level-2 
mobility problems (M2) and leve-3 mobility problems (M3) were associated with a 
disutility of 0.114 and 0.290, respectively, in the RE model including the main 
effects and the N3 term. As can be seen in Table 4.3, N3 and D1 models performed 
 
    Anxiety / depression 
      Some problems 













Chapter 4. Valuation of EQ-5D-3L health states  Wang, Pei 
72 
 
better than main-effects models in prediction bias measured by ICC and prediction 
precision measured by MAE. The LM test suggested that the RE and FE estimators 
were more appropriate than the OLS estimator (p<0.0001 for all). The Hausman test 
indicated that the RE estimator was not as efficient as the FE estimator for all the 
model specifications (p<0.05 for both). Predictions of all models using the 
individual-level data did not pass the Breusch-Pagan test for heteroskedasticity or 
Shaprio-Wilk test for normality of residuals (p<0.001), suggesting certain degrees of 
model mis-specification. 
 
Modeling results of the mean TTO scores for the 80 health states using the OLS 
estimator are displayed in Table 4.4. Regression coefficients estimated for the main 
effects, N3 and D1 terms were statistically significant and in the ranges as we 
expected. Similar to findings in individual-level modeling, the N3 and D1 models 
outperformed the main-effects models in prediction bias and precision. However, 
different from models based on individual-level data, all the models based on the 
aggregate data passed the Breusch-Pagan test for heteroschediscity and Shaprio-Wilk 
test for normality of residuals. For example, P-values of the two tests for N3 model 
without a constant were 0.327 and 0.510, respectively. Bland-Altman plots revealed 
that the N3 model without a constant generally did not suffer from prediction bias at 
any segments of the utility scale, while all other models predicted lower TTO values 
for health states with mild and/or severe health problems (Figure 4.1).        
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Table 4.3 Parameter estimates and goodness-of-fitness statistics at individual level using Fixed effect (FE) and random effect (RE) 
regression  
All coefficients are statistically significantly at 0.05 confidence level 
FE fixed effect regression RE random effect regression M2 mobility level 2 M3 mobility level 3 S2 self-care level 2 S3 self-care level 3  
Variable FE    RE   
Main 
effect  









Constant 0.1626 0.1059  0.1544  0.0978   
M2 0.0932 0.0856  0.1028 0.1352 0.0940 0.1135 0.2018 
M3 0.2952 0.2759  0.3011 0.3204 0.2788 0.2898 0.5390 
S2 0.1380 0.1619  0.1369 0.1588 0.1607 0.1751 0.2736 
S3 0.3370 0.3049  0.3407 0.3487 0.3083 0.3119 0.5498 
U2 0.2528 0.2058  0.2559 0.2840 0.2095 0.2249 0.3176 
U3 0.4534 0.3163  0.4518 0.4673 0.3162 0.3202 0.5409 
P2 0.1483 0.1306  0.1468 0.1757 0.1288 0.1458 0.2443 
P3 0.3499 0.2294  0.3460 0.3768 0.2252 0.2392 0.4812 
A2 0.1110 0.1323  0.1116 0.1336 0.1329 0.1472 0.2299 
A3 0.3645 0.2694  0.3643 0.3884 0.2685 0.2794 0.5240 
D1        -0.1148 
I3square        -0.0456 
N3  0.2816    0.2825 0.2940  
ICC 0.910 0.937  0.908 0.914 0.939 0.935 0.928 
MAE 0.1334 0.1137  0.1326 0.1393 0.1125 0.1187 0.1288 
No. (of 80) >0.1 42 37  43 37 38 43 40 
No. (of 80) >0.2 18 15  17 21 13 14 19 
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U2 usual activities level 2 U3 usual activities level 3 P2 pain / discomfort level 2 P3 pain / discomfort level 3 A2 anxiety / depression level 2 
A3 anxiety / depression level 3 D1 number of domains with problems beyond the first I3square the square term of I3 that is the number of 
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Table 4.4 Parameter estimates and goodness-of-fitness statistics at aggregated 
level using OLS regression  
All coefficients are statistically significantly at 0.05 confidence level 
OLS ordinary least square M2 mobility level 2 M3 mobility level 3  
S2 self-care level 2 S3 self-care level 3 U2 usual activities level 2 U3 usual activities 
level 3 P2 pain / discomfort level 2 P3 pain / discomfort level 3 A2 anxiety / 
depression level 2 A3 anxiety / depression level 3 D1 number of domains with 
problems beyond the first I3square the square term of I3 that is the number of 
domains at level 3 beyond the first N3 any domains on level 3 ICC intraclass 
correlation coefficient MAE mean absolute error 
 










Constant 0.1335  0.0809   
M2 0.1558 0.2017 0.1419 0.1678 0.2658 
M3 0.3280 0.3549 0.2906 0.3040 0.6961 
S2 0.1160 0.1489 0.1409 0.1615 0.2485 
S3 0.3826 0.3944 0.3421 0.3465 0.6493 
U2 0.2730 0.3184 0.2316 0.2555 0.3649 
U3 0.4240 0.4549 0.3099 0.3209 0.6115 
P2 0.1469 0.1857 0.1249 0.1462 0.2529 
P3 0.3289 0.3694 0.2125 0.2291 0.5716 
A2 0.1080 0.1439 0.1280 0.1501 0.2376 
A3 0.3563 0.3942 0.2620 0.2784 0.5219 
D1     -0.1310 
I3square     -0.0915 
N3   0.2740 0.2905  
ICC 0.914 0.919 0.938 0.941 0.938 
MAE 0.1324 0.1318 0.1125 0.1137 0.1153 
No. (of 
80) >0.1 
45 42 37 35 34 
No. (of 
80) >0.2 
17 15 13 13 14 
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Figure 4.1 Bland-Altman plots of actual and predicted scores based on OLS regression at aggregated level. X axis is the average between 
actual and predicted scores; Y axis is the actual scores minus predicted scores. Model A: main effect model with a constant; Model B: 
main effect model without a constant; Model C: N3 model with a constant Model D: N3 model without a constant; Model E: D1 model  
  
                 Model A                              Model B                             Model C 
  
                 Model D                              Model E 
The middle dotted lines stand for mean differences between actual and predicted scores; the upper and lower dotted lines stand for ±1.96 
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standard deviation of the mean differences.  




It is worth noting that the design of our study differs from that of past EQ-5D-3L 
valuation studies in several ways. First, health states considered worse than death 
were valued using the lead-time TTO method ( Devlin et al, 2011) which allowed 
health states better and worse than death to be measured in the same timeframe, that is, 
10 years. In MVH and other EQ-5D-3L valuation studies, states better and worse than 
death were valued using different time frames and scenarios. It should be noted that 
the lead-time TTO allows valuation of states better and worse than death using a 
uniform procedure (Devlin et al, 2011). However, we did not use the lead-time TTO 
to value states better than death because lead-time TTO resulted in low values for 
states better than death in a previous study (Luo et al, 2013). Another difference 
between lead-time and classic TTO procedures is data censoring. The negative value 
in our study and the MVH study was censored at -1.0 and -39, respectively. In the 
MVH study, all negative values were arbitrarily compressed to the range of -1.0 to 0; 
in contrast, we did not perform such data transformation. Therefore, the estimated 
values in our and previous studies were not really comparable.  
 
Second, we measured approximately one third of all the EQ-5D-3L health states 
which were observed in empirical studies. Most previous studies estimated the 
EQ-5D-3L value set based on only 42 directly measured health states (Dolan, 1997; 
Shaw et al, 2007; Yusof et al, 2012; Golicki et al, 2010; Jelsma et al, 2002; Lamers et 
al, 2006; Cleemput, 2010; Wittrup-Jensen, 2002). We think selecting health states 
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observed in reality is more meaningful than selecting health states in order to evenly 
cover the whole space the descriptive system defines. This is because some of 
EQ-5D-3L health states are never or rarely observed in health surveys because those 
states are either implausible (e.g. 33111) or too severe (e.g. 33333). Valuation of those 
rarely observed health states would be difficult to respondents and the values of those 
states are less useful. Therefore, we selected health states by reviewing primary 
EQ-5D-3L data collected from various populations. By directly valuing 
approximately one third of the 243 EQ-5D-3L health states, we substantially reduce 
the interpolation space for estimating the value set. Theoretically, the smaller the 
interpolation space, the smaller the prediction bias (i.e. systematic error) for the 
unobserved health states would be. Nevertheless, the increase of the number of health 
states was at the cost of decreasing the number of observations for each health state, 
given that the sample size and the number of health states each participant valued 
were fixed. As a result, the prediction precision (i.e. random error) for the observed 
health states was impaired (see below for more discussion on prediction precision).  
 
Third, we asked all respondents to state preferences for the same set of health 
scenarios in each TTO task and posed those scenarios to respondents in two different 
orders. In contrast, TTO tasks stopped as soon as respondents indicated indifference 
and each TTO task began with a scenario of 5 years of full health in the MVH study. 
A recent study showed that respondents tend to state indifference within the first few 
TTO questions (Luo et al, 2013) and an experiment in Norway found association 
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between TTO values and the starting points of the iteration procedure (Samuelsen et 
al, 2012) . Therefore, we required our respondents to consider the full range of 
scenarios even they stated indifference in the beginning of the iteration process. Using 
this design, we minimized premature responses and forced respondents to think more 
thoroughly about their answers. A previous study found that some respondents form 
their responses during the valuation tasks rather than knowing their indifference 
points before the tasks (Brazier, 2007). We did not find a significant difference in 
TTO values between respondents using different starting points, suggesting that our 
study was free from the starting point bias. 
 
Our modeling results suggest that the N3 model without a constant estimated using 
the aggregate data should be recommended for generating the EQ-5D-3L health states 
in Singapore. Our modeling results are consistent with those in previous studies in 
several ways. First, aggregated data achieved better modeling results than individual 
data. Two previous EQ-5D-3L valuation studies also recommended a model based on 
aggregated data for the same reasons – models based on individual-level data did not 
pass the tests for model misspecification (Lee et al, 2009; Liu et al, 2012). Those two 
studies directly measured approximately 100 EQ-5D-3L states which are not exactly 
same as those measured in our study. Other studies measured only 42 or fewer states 
and therefore did not perform aggregate level modeling. However, model 
misspecification was also observed in some of those studies ((Dolan, 1997; Shaw et al, 
2007; Lee et al, 2009; Wittrup-Jensen et al, 2002). Second, models with the N3 term 
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outperformed those without the term, which was the result in most of the previous 
EQ-5D-3L valuation studies (Dolan, 1997; Lee et al, 2009; Yusof et al, 2012; Golicki 
et al, 2010; Lamers et al, 2006; Cleemput et al, 2010; Wittrup-Jensen et al, 2002). 
Third, the model without a constant fit the data better than those with a constant. 
Although no EQ-5D-3L valuation studies so far recommended such a model 
specification, Brazier et al recommended a similar model specification in a study of 
SG values for SF-6D36 health states (2002). The decision was based on both utility 
theory and the modeling results. The existence of a positive constant means the value 
for full health is lower than 1.0, which is against the utility theory and therefore 
suggests the valuation method is not optimal. Our study found that the existence of 
the constant would lead to underestimated values especially for mild health states. It is 
not known whether the same effect exists in previous studies and therefore future 
studies are needed to further investigate the implications of the constant in the 
modeling of health-state utility values.          
 
On the other hand, the results of our study were markedly different from those from 
previous studies in two aspects. One noticeable difference is that the values of 
EQ-5D-3L health states to Singaporeans are lower than those to all other populations. 
A total of 145 (59.7%) EQ-5D-3L states were considered worse than death by 
Singaporeans, with the lowest value being -0.769 (for state 33333). In contrast, 84, 8, 
and 6 EQ-5D-3L states have a negative value according to the utility function 
developed in the UK (Dolan, 1997), Korea (Lee et al, 2009), and Japan (Tsuchiya et al, 
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2002), respectively. The low TTO values could be partially explained by data 
collection and analysis procedures. First of all, as we previously discussed, all other 
EQ-5D-3L valuation studies perform data transformation for negative values but we 
did not do it.  
 
Also, the duration for all health states was 10 years in our study while in all other 
studies the duration for states worse than death was less than 10 years. Evidence 
showed that severe health states are less preferred if they are in longer durations 
(Stalmeier et al, 2007). We suspect that this was the main reason for marked 
censoring effects in our study. In the meanwhile, we could not exclude the possibility 
that Singaporeans do not mind to die or die sooner in order to avoid severe poor 
health problems than people in other countries. Indeed, Singaporeans valued 
EQ-5D-5L health states as less desirable than Chinese in China (Luo et al, 2013). The 
reason might be the concern about healthcare costs which are mainly borne by 
individuals in Singapore. A recent study found that Singaporean cancer patients would 
not choose to use better but more expensive treatment if they had to pay for it (BMJ 
Group Blogs, 2013). 
 
Another major difference between our study and previous studies was model fit. 
Model fit in our study was poorer than that in previous studies. The MAE of all the 
models in our study was > 0.10 while the MAE in previous studies ranged from 0.02 
(Tsuchiya et al, 2002) to 0.08 (Tongsiri, et al, 2011). The poorer model prediction 
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precision was unlikely due to the large number of health states valued because the 
MAE in a Korean study (states valued: 101) (Lee et al, 2009) and a Chinese study 
(states valued: 97) (Liu et al, 2012) was less than 0.03. The poorer prediction 
precision of our models was an indication of greater data variability which should be 
the joint effects of several design factors. First, multiple starting points in the 
valuation exercise should have resulted in greater variance in data. TTO values were 
found to be associated with the starting point (Samuelsen et al, 2012). Different from 
our study, all previous EQ-5D-3L valuation studies followed the MVH protocol to use 
a single starting point. Second, we used a relatively small number of respondents to 
value a large number of health states. As a result, each health state was only rated by 
approximately 60 respondents. Third, we did not transform negative values as 
investigators of previous studies. The transformation performed in other studies 
compressed data distribution and variability.  
 
The main limitation of the study was the small number of observations for each health 
state. It should have contributed to the relative poor prediction precision of our 
models. However, the small number of observations per state allowed valuation of 80 
health states which reduced the interpolation space and the predication bias for 
unobserved health states. Another limitation of our study was inclusion of 
English-speaking Singaporeans only. Due to limited resources, we excluded 
Singaporeans who cannot speak English. It should be noted that it is important to use 
a representative sample in such a valuation study. However, English is the primary 
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language of academic education in Singapore and about 80% of the total Singapore 
population can speak English (Pakir, 1999). In addition, another study which is 
currently under way comparing health-state preference values across subgroups of 
Singaporeans found that survey language may not have significant impact on 
health-state preferences. Lastly, we did not ask respondents to rank and rate the health 
states before the TTO tasks as previous studies. The ranking and rating exercises may 
familiarize the participants with those health states and result in more accurate TTO 
values.   
 
In conclusion, the time trade-off value set for the EQ-5D-3L can be estimated using 
the modeling approach in the multi-cultural, multi-ethnic Singapore. Although the 
estimation precision is not optimal, domestic preference values for EQ-5D-3L health 
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Chapter Five- Predicting preference-based SF-6D36 index 
scores from the SF-8 health survey 
 
Introduction  
Cost-utility analysis (CUA) is increasingly used when a decision-maker evaluates a 
potentially more effective, yet more expensive intervention or health technology 
(Drummond et al., 2005; Bloom, 2004). In such economic evaluations, the 
effectiveness outcome is often measured as life-years weighted by health-state utilities, 
or quality-adjusted life-years (QALYs). The preference-based health-status instrument 
is a convenient approach to obtain health-state utility scores. Examples of 
preference-based measures include the quality of wellbeing scale (QWB) (Patrick and 
Erickson, 1993), the EQ-5D-3L (Dolan, 1996), the health utilities index (HUI) (Feeny 
et al, 2002), and the Short Form 6-dimensions (SF-6D36) (Brazier et al, 2002) which is 
a multi-attribute health classification system developed from the short form 36 health 
survey (SF-36) (Ware et al, 1993).  
 
It is common that researchers who want to conduct CUA find the available 
effectiveness data that were only collected by psychometric (or profile-based) 
instruments which measure the severity of the health problems but not the disutility or 
utility associated with the health outcomes. In such situations, CUA can be conducted 
only if there is a function available to convert the non-preference-based data into 
preference scores. Hence, such utility prediction functions are valuable in CUA. 
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Recent years have seen an increasing number of studies developing functions to 
predict preference scores from profile-based quality-of-life instruments through the 
modeling approach (Brazier et al, 2002; Chuang and Kind, 2009; Sengupta et al, 2004; 
Ara and Brazier, 2009; Hanmer, 2009; Gray et al, 2006; Rowen et al, 2009; Cheung et 
al, 2008; Sullivan and Ghushchyan, 2006; Franks et al, 2004; Lawrence et al, 2004). 
Such prediction approach has been accepted by NICE as a valid method for 
generating utility scores for CUA (NICE, 2012).  
 
The SF-8 is a recently developed tool within the class of SF health surveys, which are 
the most widely used health status measures in health outcomes research (Ware et al, 
2001). It is derived from the SF-36 for the purposes of yielding comparable scores for 
the 8 health dimensions and 2 summary measures of the SF-36 with minimal 
respondent burden. While the SF-8 is substantially shorter than the SF-36, it covers a 
narrow range of SF-36 scores and is less precise (Ware et al, 2001). Also, the SF-8 
health survey is a profile-based instrument that cannot be used to calculate QALYs. In 
contrast, methods have been available for deriving the preference-based SF-6D36 
score from the SF-36 and SF-12, both at the individual level and the group level (Ara 
and Brazier, 2009; Hanmer, 2009; Brazier and Roberts).  
 
The aim of this study was to develop a function for generating the preference-based 
SF-6D36 index scores from the SF-8. For this purpose, we tested seven different 
predicting models using data collected from a large-scale population health survey in 
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The SF-8 health survey is an 8-item health-related quality-of-life instrument. Each of 
the 8 items measures a different health dimension: physical function (PF), 
role-physical(RP), bodily pain (BP), general health (GH), vitality (VT), social 
function (SF), mental health (MH), and role emotional (RE) (Ware et al, 2001). Each 
item uses a 5- or 6-point Likert-type scale. The SF-8 raw item scores can be 
transformed into 8 dimension scores by assigning the mean SF-36 scale score from 
the 2,000 general US populations to each response category of the SF-8 measuring the 
same concept. Moreover, factor score coefficients are assigned to each item to 
generate two summary scores: the physical component summary (PCS) and the 
mental component summary (MCS) (Ware et al, 2001). Both dimension and the 
summary scores are scored with mean of 50 and standard deviation of 10 and higher 
scores indicating better health (Ware et al, 2001). The SF-8 has been well validated in 
various populations (Roberts et al, 2008; Bost et al, 2007; Lefante et al, 2005; 
Sugimoto et al, 2008) and the SF-36 from which the SF-8 was developed was also 








Brazier et al. established a preference-based health measure from the SF-36 (Brazier 
et al, 2002). They used a selection of eleven SF-36 items to construct a six-attribute 
health classification system: physical function, role limitation, social function, pain, 
mental health, and vitality (Brazier et al, 2002). The SF-6D36 system defines totally 
18,000 health states. Using the standard gamble valuation technique, a representative 
sample of 611 members of the UK general population was interviewed to estimate the 
utility scores of the SF-6D36 health states. The range of SF-6D36 index score is from 
0.296 to 1, where 0.296 corresponds to the worst health state and 1 corresponds to the 
best health state (Brazier et al, 2002). In our study, the SF-6D36 scores were calculated 
using responses to the SF-36 questions. 
 
Data 
We developed the prediction equation using data from a previous cross-sectional 
survey investigating cardiovascular risk factors for the general population in 
Singapore (Wee et al, 2010). In this study, a total of 10,747 participants were 
interviewed face-to-face using a questionnaire consisted of the SF-8 health survey, the 
SF-36 health survey, and questions covering demographic characteristics, lifestyle 
factors, and health conditions. All participants were randomly selected from the 
Singapore general population, with a stratified sampling design to oversample the 
minority ethnic groups (Malays and Indians) (Wee et al, 2010). 
 




The overall aim of this study is to identify the „best‟ model for predicting the SF-6D36 
index scores based on the SF-8 data. Four groups of ordinary least-square (OLS) 
models with different independent variables were assessed for predicting the SF-6D36 
index scores. Model I used SF-8 raw item scores as predictors. The raw item score for 
each item ranges from 1 to 5 or 6, with 1 representing best level of health and 5 or 6 
representing worst level. In this model, the 8 raw item scores were treated as 
continuous variables. Models II and III adopted the SF-8 dimension scores and 
summary scores (i.e. PCS and MCS) as independent variables, respectively. Model IV 
is similar to Model I in that the 8 raw items were the independent variables. However, 
the raw item scores were treated as categorical data in this case. Hence, dummy 
variables were generated for each item score. For instance, for the item measured on a 
5-point scale for physical functioning, 4 dummy variables were generated. 
 
All first-order two-way interactions of independent variables (including squared terms) 
were tested for Models I, II, and III. Interactions were not tested for Model IV due to 
its similarity with Model I. Therefore, we estimated a total of seven regression models: 
the main-effect models without interaction terms (Models Ia, IIa, IIIa, and IV) and the 
main-effect models with interaction terms (Models Ib, IIb, and IIIb). In our analyses, 
multicollinearity was examined but not resolved because the purpose of the modeling 
was to achieve good prediction rather than identifying predictors. The general form of 
the OLS models can be written as follows: 
Chapter 5. Predicting SF-6D from SF-8  Wang, Pei 
90 
 
Y = α+β1X1+β2X2 +ε 
where Y represents the SF-6D36 index score; α is the regression intercept. X1 indicates 
the SF-8 variables (main effect); and X2 is the first-order interactions between the 
SF-8 variables.β1 and β2 are regression coefficients of the corresponding independent 
variables; and ε is the residual of the regression model. The stepwise variable 
elimination procedure was used for X2 selection (Ara and Brazier, 2009). 
 
Model estimation and evaluation 
The predictive performance of the models was evaluated through a simple, one-round 
cross-validation approach. The study sample was randomly partitioned into two 
mutually exclusive subsets of equal size. One subset of data („modeling‟ dataset) was 
used for model estimation while the other subset („validation‟ dataset) was used for 
evaluating the prediction performance of the tested models. All models were assessed 
for predictive performance using a number of goodness-of-fit measures including 
adjusted R
2
, root mean squared error (RMSE), mean absolute error (MAE), and 
percentage of prediction errors smaller than 0.05, 0.10, and the minimally important 
difference (MID) of SF-6D36 scores (i.e. 0.042) (Walters and Brazier, 2005) in 
absolute magnitude. Distributional statistics (i.e. mean, standard deviation, maximum, 
and minimum) of the predicted SF-6D36 index scores were also examined. 
 
Model prediction was also assessed at the group level since the published SF-8 data 
were mostly in the form of mean values. For this purpose, a total number of 49 
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homogeneous subgroups of respondents were defined according to different 
demographics (i.e. age, gender, income, year of education, and house type) and 
chronic conditions (i.e. hypertension, diabetes, lung disease, pain, mental illness, 
cancer, and coronary heart disease) for both „modeling‟ and „validation‟ dataset. For 
each model tested, RMSE, MAE, and percentage of prediction errors less than the 
MID in absolute magnitude were calculated based on predicted and observed mean 
scores of those groups. In this analyses, the predicted group-level SF-6D36 scores were 
calculated using the group mean SF-8 scores for models I, II, and III and the group 
proportion of each SF-8 items for model IV. 
 
We also assessed the interchangeability between the actual SF-6D36 scores and 
predicted scores generated from all models using intraclass correlation coefficient 
(ICC). The ICC values range from 0 to 1, with larger values indicating higher degree 
of agreement (Fayers and Machin, 2005). ICC values of at least 0.7 and 0.9 are 
considered satisfactory for group comparison and individual comparison, 
respectively(Nunnally and Bernstein, 1994). 
 
After the specifications of the aforementioned models were determined, model 
parameters were re-estimated using data from the entire sample (i.e., both ‟modeling‟ 
and ‟validation‟ datasets). 
 
 




A total of 7,529 respondents provided data for this study. The mean age of the sample 
was 50 years (range: 14–96), with female 52.6 % of the total. The distribution of 
SF-6D36 index scores was skewed with mean and median being 0.796 (standard 
deviation: 0.124) and 0.845 (range: 0.319–1). The socio-demographic characteristics 
of the study sample and the distributions of the SF-8 and SF-6D36 scores are 
summarized in Table 5.1. 
 
Individual-level prediction 
The main effects of all the independent variables in the 7 models were statistically 
significant when the models were tested with the „modeling‟ dataset. Table 5.2 shows 
the adjusted R2 ranged from 55.9 to 62.1 %, MAE ranged from 0.056 to 0.063, and 
RMSE ranged from 0.076 to 0.082; 42.5 to 51.5 % of prediction errors was smaller 
than MID, 51.8–59.2 % of prediction errors was smaller than |0.05|, and 77.9–84.3 % 
of prediction errors was smaller than |0.10|. The mean predicted values were identical 
to the mean of the observed SF-6D36 scores for all models; however, the standard 
deviation and the maximum of the predicted scores (range: 0.899–0.933) were smaller 
than those of the observed scores (highest score = 1.0) while the minimal predicted 
scores (range: 0.200–0.509) were either higher or lower than the observed minimal 
score (i.e. 0.319) depending on the model specifications. Furthermore, the predicted 
scores generated from models with interaction terms and Model IV were all within the 
possible range of SF-6D36 scores (0.296–1). Among them, the PCS, MCS scores with 
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interaction terms (Model IIIb) covered 80.6 % of the actual range of SF-6D36 scores 
(0.319–1) in the dataset compared with 60.6–75.5 % for other models. Plotting the 
residuals, predicted and actual SF-6D36 scores showed that Model IIIb (Figure 5.1) 
and all other models (data not shown) predicted lower scores at the higher end of the 
SF-6D36 scale and scores with greater variance at the lower end of the scale. Model fit 
was similar across models for the „validation‟ dataset (Table 5.3).  
 
The ICC values at individual level ranged from 0.730 to 0.775 for the „modeling‟ 
dataset and 0.717–0.766 for the „validation‟ dataset, respectively. 
Table 5.1 Socio-demographic characteristics and health status of the study sample (N=7,529) 
 Number (%) SF-6D36 PCS-8 MCS-8 
 Mean SD
a
 Mean SD Mean SD 
Full sample 7,529 (100.0) 0.796 0.124 52.22 6.32 52.84 6.66 
Age (year)        
<45  2,748 (36.5) 0.811 0.120 53.73 5.20 52.62 6.68 
45-64 3,742 (49.7) 0.797 0.121 52.10 5.95 53.16 6.40 
>=65  971 (12.9) 0.752 0.136 48.38 8.54 52.17 7.52 
Gender        
Female 3,960 (52.6)  0.782 0.126 51.56 6.57 52.39 6.88 
Male 3,569 (47.4) 0.812 0.120 52.95 5.94 53.32 6.38 
Ethnicity        
Chinese 5,481 (72.8) 0.804 0.123 52.21 6.05 52.92 6.33 
India 648 (8.6) 0.772 0.138 50.56 7.42 52.02 7.58 
Malay 1,400 (18.6) 0.792 0.133 51.31 6.45 53.09 6.41 
Education         
No  459 (6.1) 0.736 0.137 47.50 9.05 51.23 7.98 
1-3 years 264 (3.5) 0.780 0.126 50.16 7.28 53.06 6.36 
4-6 years 1,242 (16.5) 0.791 0.122 51.39 6.43 52.88 6.60 
7-10 years 2,688 (35.7) 0.796 0.123 52.23 6.11 53.00 6.54 
>=10 years 2,681 (38.0) 0.810 0.120 53.51 5.29 52.90 6.58 
Monthly income (S$)        
<=2000  1,318 (17.5) 0.761 0.133 50.31 7.34 51.71 7.76 
2001-4000  1,468 (19.5) 0.794 0.129 51.98 6.16 53.09 6.90 
4001-6000  715 (9.5) 0.789 0.126 52.45 5.66 52.40 7.06 
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6001-10000  550 (7.3) 0.802 0.114 53.34 4.93 53.05 6.32 
>10000  324 (4.3) 0.827 0.110 53.89 4.60 53.61 6.25 
House type        
1 or 2 room  151 (2.0) 0.766 0.138 49.88 8.33 51.16 7.96 
3 room  1,182 (15.7) 0.790 0.126 51.64 6.93 52.57 6.75 
4 room  2,756 (36.6) 0.797 0.123 52.12 6.18 52.78 6.54 
5 room  2,281 (30.3) 0.795 0.124 52.49 6.21 52.79 6.88 
Condo  625 (8.3) 0.807 0.118 52.82 5.66 53.61 6.08 
Landed  520 (6.9) 0.810 0.126 52.90 5.68 53.41 6.34 
Chronic conditions        
Hypertension  1,386 (18.4) 0.762 0.131 49.47 7.55 52.21 7.18 
Diabetes  647 (8.6) 0.746 0.138 48.51 8.14 51.42 7.79 
Coronary heart disease  399 (5.3) 0.786 0.123 51.48 6.82 52.56 6.82 
Lung disease  324 (4.3) 0.777 0.130 51.30 6.60 52.31 7.12 
Pain  1,363 (18.1) 0.789 0.125 51.84 6.51 53.00 6.59 
Mental illness 68 (0.9) 0.796 0.125 51.51 7.33 52.30 7.22 
Cancer  67 (0.9) 0.787 0.130 51.04 6.92 52.36 6.71 
Stroke  68 (0.9) 0.676 0.148 41.42 11.27 47.59 12.42 



















Table 5.2 Goodness of fit of the tested OLS models in the modeling dataset  

















Mean 0.796 0.796 0.796 0.796 0.796 0.796 0.796 0.796 
SD 0.124 0.095 0.098 0.093 0.097 0.093 0.095 0.097 
Min 0.319 0.246 0.502 0.210 0.509 0.200 0.384 0.408 
Max 1.000 0.905 0.926 0.899 0.922 0.911 0.933 0.922 
         
Adj R
2
  0.584 0.620 0.566 0.613 0.559 0.580 0.621 
MSE  0.006 0.006 0.007 0.006 0.007 0.006 0.006 
MAE  0.060 0.056 0.062 0.057 0.063 0.061 0.056 
RMSE  0.080 0.077 0.082 0.077 0.082 0.080 0.076 
<|0.10|*  79.3% 83.6% 77.9% 84.1% 78.2% 81.4% 84.3% 
<|0.05|*  53.4% 56.2% 51.8% 55.3% 52.2% 52.3% 59.2% 
 <MID*  45.7% 50.3% 43.9% 48.8% 42.5% 45.0% 51.5% 




Mean 0.774 0.779 0.780 0.779 0.780 0.779 0.780 0.782 
SD 0.134 0.108 0.104 0.103 0.107 0.103 0.105 0.108 
 Min 0.403 0.268 0.558 0.227 0.547 0.212 0.390 0.427 
 Max 0.996 0.901 0.919 0.896 0.920 0.910 0.930 0.922 
          
 ME  0.0051 0.0058 0.0051 0.0058 0.0049 0.0060 0.0079 
MAE  0.0077 0.0075 0.0076 0.0076 0.0076 0.0079 0.0091 
RMSE  0.0112 0.0108 0.0111 0.0105 0.0117 0.0119 0.0121 
<MID*  100% 100% 100% 99% 100% 100% 100% 
Model Ia: SF-8 raw item scores without interaction; Model Ib: SF-8 raw item scores with interaction; Model IIa: 
SF-8 dimension scores without interaction; Model IIb: SF-8 dimension scores with interaction; Model IIIa: SF-8 
PCS MCS scores without interaction; Model IIIb: SF-8 PCS MCS scores with interaction; Model IV: SF-8 raw 
item score model (treated as categorical data). * Percentage of cases for whom the difference between actual and 
predicted scores was less than 0.10, 0.05, or MID (0.042). 
OLS: ordinary least-square; SD: standard deviation; MSE: mean square error; MAE: mean absolute error; RMSE: 













Table 5.3 Goodness of fit of tested OLS models in the validation dataset  

















Mean  0.796 0.794 0.794 0.796 0.796 0.796 0.796 0.794 
SD 0.124 0.099 0.099 0.098 0.099 0.097 0.097 0.099 
Min 0.370 0.220 0.475 0.184 0.494 0.181 0.384 0.409 
Max 1.000 0.905 0.926 0.899 0.922 0.911 0.933 0.922 
         
MSE  0.006 0.006 0.007 0.006 0.007 0.006 0.006 
MAE  0.061 0.056 0.062 0.057 0.063 0.063 0.058 
RMSE  0.082 0.077 0.082 0.078 0.084 0.081 0.076 
<|0.10|*  79.2% 83.5% 77.4% 83.6% 78.2% 81.3% 84.0% 
<|0.05|*  53.2% 56.1% 52.3% 54.8% 52.3% 51.9% 59.2% 
 <MID*  46.6% 49.8% 45.4% 48.6% 43.4% 45.5% 51.3% 




Mean 0.784 0.781 0.783 0.780 0.782 0.780 0.781 0.785 
SD 0.138 0.111 0.110 0.110 0.111 0.109 0.106 0.112 
Min 0.401 0.265 0.539 0.224 0.543 0.210 0.391 0.423 
 Max 0.998 0.902 0.921 0.897 0.921 0.911 0.933 0.922 
          
 ME  -0.0034 -0.0010 -0.0041 0.0014 -0.0042 -0.0020 0.0009 
MAE  0.0075 0.0072 0.0080 0.0070 0.0075 0.0061 0.0073 
RMSE  0.0111 0.0099 0.0118 0.0097 0.0097 0.0091 0.0100 
<MID*  100% 100% 100% 100% 100% 100% 100% 
Model Ia: SF-8 raw item scores without interaction; Model Ib: SF-8 raw item scores with interaction; Model IIa: 
SF-8 dimension scores without interaction; Model IIb: SF-8 dimension scores with interaction; Model IIIa: SF-8 
PCS MCS scores without interaction; Model IIIb: SF-8 PCS MCS scores with interaction; Model IV: SF-8 raw 
item score model (treated as categorical data). * Percentage of cases for whom the difference between actual and 
predicted scores was less than 0.10, 0.05, or MID (0.042). 
OLS: ordinary least-square; SD: standard deviation; MSE: mean square error; MAE: mean absolute error; RMSE: 
















Figure 5.1 Residuals and SF-6D36 scores predicted by Model IIIb (PCS, MCS, PCS*MCS) 
for the modeling dataset (N=3,765). Observations are ordered from low to high according to 
the actual SF-6D36 scores. The Y axis illustrates the magnitude of actual, predicted 
scores and residuals. The X axis shows different observations from low to high 
according to the actual SF-6D scores.  
 
        
               Actual SF-6D36     Predicted SF-6D36     Residuals 
 
Group-level prediction 
In general, all 7 models predicted similar-to-actual mean SF-6D36 scores for 49 
subgroups differing in demographics or health status. For each model, almost 100 % 
proportion of the differences between observed and predicted means scores was 
smaller than the MID of SF-6D36 (Table 5.2). The MAE and RMSE calculated based 
on these mean scores ranged from 0.0075 to 0.0091 and 0.0105 to 0.0121, 
respectively. Scatter plots (Figure 5.2) revealed that Model IIIb predicted slightly 
lower scores at the higher end of the SF-6D36 scale for the „modeling‟ dataset. When 
the estimated models were applied to the „validation‟ dataset, similar goodness-of-fit 
results were observed (Table 5.3).  
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The ICC values at group level were 0.959–0.968 for „modeling‟ dataset and 
0.949–0.954 for „validation‟ dataset, respectively. 
 
Overall, for predicting both individual scores and group mean scores, the tested 
models had similar performance. However, the prediction performance at the group 
level was better than that at the individual level. The parameters of the 7 models 
estimated using the entire dataset were displayed in Table 5.4. 
 
Figure 5.2 Scatter plot of actual and predicted mean SF-6D36 scores for 49 subgroups of 
individualsbased on the mean SF-8 PCS and MCS scores of the subgroups and their 
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          2 3 4 5 6 
PF -0.0212 -0.0490 PFnbs 0.0026 -0.0028 PCS 0.0093 -0.0046 PF -0.0272 -0.0436 -0.0497 -0.0405  
RP -0.0097 -0.0162 RPnbs 0.0013 -0.0060 MCS 0.0084 -0.0056 RP -0.0246 -0.0283 -0.0302 -0.0889  
BP -0.0262 -0.0486 BPnbs 0.0041 -0.0069 PCS*MCS  0.0003 BP -0.0402 -0.0483 -0.0659 -0.0984 -0.0944 
GH -0.0064 -0.0076 GHnbs 0.0011 0.0013    GH -0.0059 -0.0110 -0.0231 -0.0186 -0.0200 
VT -0.0219 -0.0564 VTnbs 0.0025 -0.0142    VT -0.0313 -0.0507 -0.0631 -0.0408  
SF -0.0224 -0.0475 SFnbs 0.0022 -0.0027    SF -0.0362 -0.0307 -0.0506 -0.0705  
RE -0.0252 -0.0613 REnbs 0.0036 -0.0163    RE -0.0455 -0.0606 -0.0592 -0.0344  
MH -0.0266 -0.0432 MHnbs 0.0036 -0.0035    MH -0.0276 -0.0444 -0.0679 -0.1213  
Constant 1.0652 1.2168  -0.2908 1.3683  -0.1316 0.5462  0.9223     
               
VT*MH  0.0082 VT*MH  0.0001          
SF*RE  0.0146 PF*SF  0.0001          
PF*PF  0.0067 RP*RP  0.0001          
BP*BP  0.0049 BP*BP  0.0001          
VT*VT  0.0046 VT*VT  0.0001          
Model Ia: SF-8 raw item scores without interaction; Model Ib: SF-8 raw item scores with interaction; Model IIa: SF-8 dimension scores without interaction; Model IIb: SF-8 dimension scores 
with interaction; Model IIIa: SF-8 PCS MCS scores without interaction; Model IIIb: SF-8 PCS MCS scores with interaction; Model IV: SF-8 raw item score model (treated as categorical 
data).  
OLS: ordinary least-square; PF: physical functioning; RP: role-physical; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role emotional; MH: mental health. 
PFnbs: physical functioning normalized score; RPnbs: role-physical normalized score; BPnbs: bodily pain normalized score; GHnbs: general health normalized score;  
VTnbs: vitality normalized score; SFnbs: social functioning normalized score; REnbs: role emotional normalized score; MHnbs: mental health normalized score. 
PCS: physical component summary score; MCS: mental component summary score.  
The interaction terms presented in the table were all statistically significant.




In this study, we developed and tested functions for predicting the SF-6D36 scores 
from the SF-8. With these functions available, cost-utility analysis can be conducted 
in situations where patients‟ health outcomes are only measured by the SF-8 without 
any preference-based health measures. To the best of our knowledge, there is no 
function for estimating utility index scores from the SF-8.  
 
While the OLS models we tested can successfully predict SF-6D36 scores, our models 
do not fit the data as well as the models developed by Ara and Brazier (2009) for the 
SF-36 and Hanmer (2009) for the SF-12. The adjusted R
2
 of the OLS functions we 
tested was 56–58 %, respectively, compared to the R2 in those two studies ranged 
from 83 to 88 %. Similarly, when modeling the individual-level data, approximately 
50–80 % of predicted values were with an error of<0.05–0.10, respectively, in our 
study. In contrast, 77–95 % of predicted SF-6D36 scores were with an error of <0.05 
and<0.10, respectively, in Ara and Brazier‟s model. The relatively higher goodness of 
fit of their models could be due to that the SF-6D36 was derived from the SF-36 or 
SF-12 but not the SF-8. 
 
 In general, the OLS models performed well at the group level in predicting mean 
SF-6D36 scores. In our study, the ICC values were all above the threshold for group 
comparison. The difference between predicted and observed SF-6D36 mean scores is 
smaller than the MID of SF-6D36 scores (i.e. 0.042) for almost all of the 49 subgroups 
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(Tables 5.2 and 5.3). In contrast, only 90 % of subgroup mean scores were predicted 
with an error smaller than the MID in Ara and Brazier‟s study (2009). Hence, it seems 
that the functions we developed can be used to generate preference-based SF-6D36 
scores for groups of individuals whose health status are measured by the SF-8, if 
investigators need to perform post hoc cost-utility analysis. Although all functions we 
examined have similar performance in predicting SF-6D36 scores, the function using 
the SF-8 PCS and MCS scores, and their interaction term (Model IIIb) could be more 
useful than other models in practice. First, the predicted scores cover most of the 
actual SF-6D36 range. Second, in the literature, the SF-8 data are usually published in 
mean PCS, MCS, and/or dimension scores that can also be used to estimate PCS and 
MCS scores. Third, the function is parsimonious by using less number of parameters. 
Meanwhile, it should be noted that the Model IIIb and all other models with 
interaction terms predicted higher scores at the lower end of the SF-6D scale. Hence, 
using the model to predict low SF-6D scores is not recommended. It also should be 
noted that modelsⅠand Ⅳ, although modeled the same effect, showed different 
goodness-of-fit statistics. This is not surprising because model Ⅳ has many more 
independent variables than model Ⅰ. 
 
On the other hand, the models we tested were not as satisfactory in making 
predictions at the individual level compared to making predictions at the group level. 
The difference between predicted and actual scores reached or exceeded the 
minimally important difference of SF-6D36 scores (Tables 5.2, 5.3) for a large 
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proportion of the individuals in our study sample and great prediction errors existed in 
the lower end of the SF-6D36 scale (Figure 5.1). Also, all predicted scores were with 
ICC values less than 0.9 indicating that they are not interchangeable with actual 
SF-6D36 scores. Hence, using these models to predict SF-6D36 scores at the level of 
individual subjects is not recommended.  
 
Two technical issues related to our modeling strategies are worth discussion. First, we 
chose to use the OLS model to analyze our data. This decision was based on the fact 
that the OLS model was used in most studies mapping a profile-based measure onto a 
preference-based measure (Brazier et al, 2010). We noted that some investigators 
found the CLAD (Sullivan and Ghushchyan, 2006) and two-part (Li and Fu, 2009) 
models performed better than the OLS model for data with ceiling effects (i.e. a large 
proportion of individuals in the study sample being in full health). As only 4.95 % of 
individuals in our study sample had a SF-6D36 score of 1.0, we did not consider such 
models in our main analysis. Nevertheless, we subsequently modeled our data using 
the Tobit model, a two-part model (logistic plus OLS), the nonlinear spline model, 
and two neural networks models. None of these models outperformed the OLS model 
(data not shown but available on request). Second, the stepwise regression we used is 
a controversial method. However, it is less of a concern in the present study since our 
study was exploratory and our goal was to achieve the best model fit. Pervious 
mapping studies also used the stepwise selection method (Ara and Brazier, 2009). We 
subsequently applied forward, backward, least angle regression (LAR), and Lasso 
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method to the model containing the main effects and all first-order interaction terms 
of the two SF-8 summary scores but the resultant model specifications did not give 
better predictions than Model IIIbs (data not shown but available on request). That 
more sophisticated methods did not produce better results suggested that the stepwise 
OLS model is sufficient for modeling our data. 
 
Our study has some limitations that should be noted. First, the prediction functions we 
came up with are based on data from a sample of the general population in which the 
proportion of very ill individuals was low. As a result, the prediction accuracy of the 
functions may not be high for patient populations with poor health status. Similarly, 
our OLS prediction functions may not work well in very healthy general populations, 
as a much higher proportion of individuals in such populations should be in full health 
(i.e. utility score = 1.0). Second, the external validity of the functions is not evaluated 
as we do not have other datasets that contain both SF-8 and SF-6D36 data from same 
respondents thus far. Without external validations, the usefulness of the resultant 
functions cannot be confirmed. Third, we were not able to assess the validity of the 
predicted scores by comparing those values with directly measured utility scores. 
Actually, this is a limitation of all mapping studies, that is, validity is only assessed by 
model fit. The strategy of deriving utility scores through a mapping function would 
benefit from comparison with utility scores for the health states of interest measured 
using direct techniques such as standard gamble or time trade-off. Fourth, the SF-6D36 
index scores were calculated using UK algorithm since the Singapore algorithm is 
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absent. It is possible that the results and conclusions would be significantly different if 
using local algorithm. Hence, future studies are warranted to compare our results with 
results based on local algorithm if it is developed.   
 
In conclusion, our study developed and compared prediction functions to generate 
preference-based SF-6D36 index scores from the SF-8 health survey, the first of its 
kind. The functions tested in the present study make cost-utility analyses possible 
with the SF-8 data. Future research is needed to further evaluate the performance and 
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Chapter Six - Preference-based SF-6D scores derived from 
the SF-36 and SF-12 have different discriminative power in 
a population health survey 
 
Introduction  
The SF-6D (Brazier et al, 2002) is an instrument for describing and valuing 
individuals‟ health. It is designed for generating a preference-based index score 
suitable for cost-effectiveness analysis from the SF-36 (Ware et al, 1993). The SF-6D 
index score can also be estimated for individuals on the basis of their responses to the 
SF-12 (Brazier and Roberts, 2004) a profile-based instrument comprising 12 of the 
SF-36 items (Ware et al, 1996). The availability of multiple approaches to generating 
the SF-6D score raises the issue of comparability between its 2 variants, namely, the 
SF-6D36 and SF-6D12. Indeed, the SF-6D36 score was found to be lower than the 
SF-6D12 score in both patient and general population samples (Pickard et al, 2005; 
Hanmer, 2009), although they demonstrated similar responsiveness to change in a 
study of multiple patient groups (Brazier and Roberts, 2004). Evidence on sensitivity 
to differences in the cross-sectional comparison of different groups (also referred to as 
discriminative power) (Streiner and Norman, 1995) was documented for both SF-6D36 
(Petrou and Hockley, 2005) and SF-6D12 (Cunillera et al, 2010); however, it is not 
known whether the 2 SF-6D scores have similar discriminative power. 
 
The purpose of the present study was to compare the ability of the SF-6D12 and 
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SF-6D36 to discriminate between different levels of health status in population health 
surveys. We also included 3 commonly used preference-based heath indices, namely, 
the EQ-5D-3L (Dolan, 1996), HUI2 (Torrance et al, 1996), and HUI3 (Feeny et al, 




We used data from the 2005 to 2006 National Health Measurement Study (NHMS), a 
cross-sectional health survey of the noninstitutionalized US population (Fryback et al, 
2007). The NHMS surveyed 4,334 individuals using a random-digit dialed telephone 
interview method. A stratified sampling design was used to oversample blacks and 
older persons. Respondents (n = 3,522) with complete data for the EQ-5D-3L, HUI2, 
HUI3, SF-36, and the profile of chronic medical conditions were included in the 
present study. The presence or absence of each of 11 conditions (i.e, coronary heart 
disease, stroke, diabetes, arthritis, eye disease, sleep disorder, respiratory disease, 
depression, ulcer, thyroid disease, and back pain) was assessed from respondents 
using the question “Have you ever been told by a doctor or other health professional 
that you had…?” 
 
Instruments 
The SF-36 (version 2.0), EQ-5D-3L, and HUI questionnaires were used to collect data 
for generating the SF-6D, EQ-5D-3L, HUI2, and HUI3 scores, respectively. Each of 
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these preference-based instruments consists of 2 components: a multiattribute 
classification system for describing an individual‟s health and a utility function for 
assigning each described health state a preference score. The classification systems 
define health using 5–8 different attributes or dimensions, each with 3–6 descriptors 
or levels. For all the instruments, their index scores reflect the health preferences of a 
general population and are measured on a scale anchored by 0 (corresponding to death) 
and 1.0 (corresponding to full health) (Brazier et al, 2002; Brazier and Roberts, 2004; 
Dolan, 1997; Torrance et al, 1996; Feeny et al, 2002). The main characteristics of the 
preference-based instruments are shown in Table 6.1. The 6-dimension classification 
systems of the SF-6D36 and SF-6D12 are identical in 3 dimensions, namely, role 
limitations, social functioning, and vitality; however, physical functioning (6 vs. 3 
levels), bodily pain (6 vs. 5 levels), and mental health (depression and nervousness vs. 
depression only) are defined with more levels or aspects in SF-6D36 than in SF-6D12. 
These differences are because the SF-6D36 and SF-6D12 systems are based on 11 and 
7 SF-12/36 items, respectively. Accordingly, the SF-6D36 and SF-6D12 define 18,000 
and 7,500 unique health states, respectively. As preference values for the SF-6D 
health states were not available from the US population, those estimated from the 
general UK population were used in this study (Brazier et al, 2002; Brazier and 
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Table 6.1 Characteristics of the preference-based instruments  
 SF-6D36 SF-6D12 EQ-5D-3L HUI2 HUI3 
Classification system      
Dimension or attribute 
(no. levels) 
 
   
PF (6) PF (3) Mobility (3) Mobility (5) Ambulation (6) 
MH (5) MH (5) AD (3) Emotion (5) Emotion (5) 
BP (6) BP (5) PD (3) Pain (5) Pain (5) 
SF (5) SF (5) UA (3) Cognition (4) Cognition (6) 
RL (4) RL (4) Self-care (3) Self-care (4) Dexterity (6) 
Vitality (5) Vitality (5)  Sensation (4) Hearing (6) 
    Speech (5) 
    Vision (6) 
No. health states defined 18,000 7,500 243 24,000 972,000 
      
Preference score      
Range 0.296-1.0 0.345-1.0 -0.11-1.0 -0.03-1.0 -0.36-1.0 










Country where the 
health preferences are 
from 
UK UK US Canada Canada 
AD – anxiety/depression; BP – Bodily pain; PF – Physical functioning; MH – Mental health; BP – 
Bodily pain; SF – Social functioning; RL – Role limitations; AD – Anxiety/depression; PD – 
Pain/discomfort; UA – Usual activities. 
 
Data Analyses 
Discriminative power was assessed according to the instruments‟ relative efficiency in 
distinguishing respondents with and without a chronic condition. Relative efficiency 
of 2 instruments was defined as the ratio of F statistics in the analysis of variance 
(ANOVA) tests of the difference in their index scores between the 2 comparison 
groups (Fayers and Machin, 2000). As a higher F-statistic value is more likely to lead 
to statistical significance, the instrument with a higher F statistic would be considered 
more efficient or discriminative. In the present study, we used the instrument with the 
largest F statistic as the reference (relative efficiency = 1) to calculate the relative 
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efficiency values of all other instruments (range, 0–1). Relative efficiency of the study 
instruments was assessed for each of 11 chronic conditions. 
 
As the discriminative power of a preference-based instrument is partially dependent 
on its health state classification system, we assessed the classification efficiency of 
the dimension scales used by each instrument using the Shannon index (H‟) (Shannon, 
1948). H‟ is defined as:  
                           
Where L is the number of descriptive levels of a dimension scale and pi is the 
proportion of respondents who endorse the ith level (i=1…L). Larger H‟ values 
indicate higher classification efficiency. In the case of an even (rectangular) 
distribution, that is, individuals are evenly distributed among all levels, H‟ reaches its 
maximum that equals log2L. Widely used as a measure of biodiversity, the Shannon 
index has also been used to assess health state classification systems (Janssen et al, 
2007). As no guidelines were available for interpreting H‟, we calculated the 95% 
confidence intervals for H
‟
 using a bootstrap method (Efron and Tibshirani, 1993). 
 
The discriminative power of the SF-6D36 and SF-6D12 was also compared in 
respondents who were on the ceiling of the EQ-5D-3L, HUI2, or HUI3 scale. These 
were respondents who reported full health with one of those instruments. We 
expected variation in health status among those respondents and hypothesized that the 
SF-6D is discriminative between those with and without chronic conditions. 
H‟= - 
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All analyses were performed using SAS survey commands (Version 9.2) (e.g. 
surveymean and surveyfreq) to account for the complex sampling design (i.e. 
combination of multi-stage stratified sampling and post-stratification) of NHMS.  
 
Results 
The characteristics of the study sample and the population it represented are 
summarized in Table 6.2. After adjusting for the complex sampling design, the mean 
age of the respondents was 53.9 years, with 52.3% being women; 71.9% of the 
respondents reported one or more chronic conditions, with the 3 most prevalent 
conditions being arthritis (39.4%), eye disease (28.2%), and back pain (18.3%). The 
proportion of respondents reporting full health on the SF-6D36 and SF-6D12 was 4.3% 
and 8.6%, respectively, and ranged from 13.6% (HUI2) to 44.3% (EQ-5D-3L) for 
other health index scores; floor effects (i.e. reporting of the worst possible health with 
an instrument) were observed only for the SF-6D12 (0.2%) and HUI3 (0.1%).  
 
The mean SF-6D36 score was lower than the mean SF-6D12 score for the entire sample 
(0.792 and 0.821, respectively) and for respondents with and without a chronic 
condition by approximately 0.03 points (Table 6.3, P < 0.001 for all comparisons). 
 
Compared with the SF-6D12, the SF-6D36 exhibited higher relative efficiency for 8 of 
the 11 conditions (Figure 6.1). Compared with all other instruments, the SF-6D36 had 
the highest relative efficiency in 5 chronic conditions (diabetes, sleep disorder, 
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respiratory disease, thyroid disease, and back pain), followed by EQ-5D-3L in 3 
conditions (stroke, arthritis, and eye disorder), HUI2 in 2 conditions (coronary heart 
disease and ulcer), and SF-6D12 in 1 condition (depression). Among the SF-6D12, 
EQ-5D-3L, HUI2, and HUI3, none of the instruments had better F-statistic values 
than all the others (Figure 6.1).  
 
The SF-6D36 had higher H‟ values than the SF-6D12 in the 3 dimensions where their 
descriptive levels are different (Table 6.4). For example, the H‟ value (95% 
confidence interval) for the dimension of physical functioning was 1.73 (1.67–1.79) 
and 0.78 (0.72–0.85) in the SF-6D36 and SF-6D12, respectively. The SF-6D36 also had 
higher H‟ values than all other instruments for dimensions assessing similar aspects of 
health. H‟ values for the similar dimensions of the SF-6D12, EQ-5D-3L, HUI2, and 
HUI3 were similar (Table 6.4). 
 
The SF-6D36 exhibited higher relative efficiency in discriminating between 
respondents with and without chronic conditions than the SF-6D12 in respondents on 
the ceiling of the EQ-5D-3L, HUI2, or HUI3 scale (Table 6.5). Moreover, using 0.041 
as the minimally important difference (Walters and Brazier, 2005), the SF-6D36 
indicated that the impact of chronic conditions on the health of respondents who 
reported full health with each of the 3 instruments was not trivial; in contrast, the 
SF-6D12 failed to capture this impact for respondents who were on the ceiling of the 
EQ-5D-3L or HUI3 scale (Table 6.5). 




Table 6.2 Demographic characteristics of the study sample 
 
Variable Level % (N), unweighted %, weighted  
Gender Male 43.1 (1,518) 47.4 
 Female 56.9 (2,004) 52.3 
    
Age 35-44 years 17.3 (608) 32.2 
 45-64 years 40.3 (1,420) 44.2 
 65-89 years 42.4 (1,494) 23.6 
    
Race White 66.6 (2,346) 82.3 
 Black 28.7 (1,012) 10.7 
 Other 4.3 (150) 7.0 
 (Missing) 0.4 (14) 0.1 
    
Annual household 
income 














Education level < High school 
High school 
Some post-high school 
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Figure 6.1 Relative efficiency of the SF-6D36, SF-6D12, EQ-5D-3L, HUI2, and HUI3 index scores in discriminating between respondents 



















Depression Ulcer Thyroid 
disease 
Back Pain 
SF-6D36 SF-6D12 EQ-5D HUI2 HUI3 
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Table 6.3 The SF-6D36 and SF-6D12 scores for respondents with and without a chronic condition  












































CHD (403) 0.719 (0.012) 0.745 (0.013) 0.026  0.799 (0.004) 0.828 (0.004) 0.029 
Stroke (183) 0.711 (0.026) 0.735 (0.025) 0.024  0.795 (0.003) 0.824 (0.004) 0.029 
Diabetes (621) 0.733 (0.010) 0.762 (0.011) 0.029  0.800 (0.004) 0.829 (0.004) 0.029 
Arthritis (1,355) 0.731 (0.006) 0.767 (0.007) 0.036  0.819 (0.004) 0.845 (0.004) 0.026 
Eye disease (969) 0.757 (0.006) 0.790 (0.007) 0.033  0.801 (0.004) 0.829 (0.004) 0.028 
Sleep disorder (307) 0.680 (0.014) 0.704 (0.016) 0.024  0.802 (0.003) 0.831 (0.004) 0.029 
Respiratory (555) 0.717 (0.010) 0.744 (0.011) 0.027  0.803 (0.004) 0.832 (0.004) 0.029 
Depression (486) 0.691 (0.011) 0.713 (0.012) 0.022  0.810 (0.003) 0.840 (0.004) 0.030 
Ulcer (421) 0.716 (0.012) 0.742 (0.012) 0.026  0.801 (0.003) 0.830 (0.004) 0.029 
Thyroid (424) 0.752 (0.009) 0.786 (0.011) 0.034  0.797 (0.004) 0.826 (0.004) 0.029 
Back pain (636)  0.684 (0.008) 0.717 (0.009) 0.033  0.815 (0.003) 0.842 (0.004) 0.027 
Any of the above 
conditions (2,553) 0.790 (0.005) 0.758 (0.004) 0.032  0.877( 0.005) 0.853( 0.005) 0.024 
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Table 6.4 Classification efficiency of the SF-6D36, SF-6D12, EQ-5D-3L, HUI2, and HUI3 systems measured by Shannon’s Indices 
PF – Physical functioning; MH – Mental health; BP – Bodily pain; SF – Social functioning; RL – Role limitation; AD – Anxiety/depression; PD 





SF-6D36   SF-6D12   EQ-5D-3L  HUI2  HUI3 
Dimension H‟ (95%CI)  Dimension H‟ (95%CI)  Dimension H‟ (95%CI)  Dimension H‟ (95%CI)  Dimension H‟ (95%CI) 
PF 1.73 (1.67-1.79)  PF 0.78 (0.72-0.85)  Mobility 0.73 (0.67-0.78)  Mobility 0.95 (0.90-1.01)  Ambulation 0.62 (0.55-0.69) 
MH 1.70 (1.65-1.74)  MH 1.39 (1.32-1.45)  AD 0.82 (0.77-0.88)  Emotion 1.15 (1.09-1.21)  Emotion 1.06 (0.99-1.13) 
BP 2.16 (2.12-2.21)  BP 1.56 (1.50-1.62)  PD 1.16 (1.12-1.19)  Pain 1.69 (1.64-1.74)  Pain 1.83 (1.78-1.90) 
SF 1.40 (1.33-1.48)  SF 1.40 (1.33-1.48)  UA 0.75 (0.69-0.80)  Cognition 1.09 (1.04-1.13)  Cognition 1.51 (1.45-1.59) 
RL 1.65 (1.60-1.70)  RL 1.65 (1.60-1.70)  Self-care 0.24 (0.20-0.28)  Self-care 0.18 (0.13-0.23)  Dexterity 0.23 (0.19-0.29) 
Vitality 1.79 (1.73-1.86)  Vitality 1.79 (1.73-1.86)      Sensation 1.21 (1.16-1.26)  Hearing 0.30 (0.25-0.35) 
                Speech 0.13 (0.10-0.18) 
                Vision 1.13 (1.08-1.18) 
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Table 6.5 The SF-6D36 and SF-6D12 scores for respondents with and without 
chronic conditions among those who were on the ceiling of the EQ-5D-3L, HUI2, 
or HUI3 scale 
Instrument Presence of 
any chronic 
conditions 




































SD: standard deviation 
* Calculated as F-statistic of SF-6D12 divided by F-statistic of SF-6D36; § Difference 























In this study, we found that the SF-6D36 is more efficient than the SF-6D12 and 3 other 
commonly used preference-based health indices in discriminating between individuals 
in differing health conditions. Thus, our study explains why the SF-6D was more 
discriminative than the EQ-5D-3L in Petrou and Hockley‟s study (2005) but not so in 
Cunillera et al‟s (2010) or Bharmal and Thomas‟s study (2006). The SF-6D score was 
derived from the SF-36 in Petrou and Hockley‟s study but from the SF-12 in the other 
2 studies. It is not surprising that the SF-6D36 is more discriminative than the SF-6D12 
because the SF-6D36 describes health in greater detail than the SF-6D12; however, 
previously, there was no evidence on this. Hence, our study makes a strong case for 
using the SF-6D derived from the SF-36 in population health surveys where a 
preference-based heath index is needed. 
 
Consistent with the finding from the present study, the SF-6D36 index score was lower 
than the SF-6D12 index score in all age groups by as much as 0.042 in a previous 
population health survey (Hanmer, 2009). This difference may be due to the 
recommended utility functions assigning the score of 1.0 to both the SF-6D36-defined 
and SF-6D12-defined full health, although the former is better than the latter. Physical 
functioning in the SF-6D36 and SF-6D12 full health is defined as no limitations in 
“vigorous activities” and “moderate activities,” respectively. Given this finding, 
comparison of absolute SF-6D scores derived from the SF-12 and SF-36 should be 
conducted with caution. The existence of this systematic difference, however, does 
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not necessarily mean that SF-6D12 and SF-6D36 cannot lead to similar results when 
they are used to quantify between group differences or within-group changes over 
time. In the present study, the magnitude of difference in health between respondents 
with and without a condition estimated by the SF-6D36 and SF-6D12 was very similar 
for all 11 conditions. For example, respondents with and without arthritis differed by 
0.088 and 0.078 according to the SF-6D36 and SF-6D12, respectively (Table 6.3). Also, 
health changes occurring in patient groups assessed by these 2 SF-6D scores were 
found to be similar for a number of conditions (Brazier and Roberts, 2004; Pickard et 
al, 2005). 
 
Our finding that the SF-6D36 was more discriminative than the EQ-5D-3L is 
consistent with the finding from a previous study comparing these 2 instruments in a 
population health survey in England (Petrou and Hockley, 2005). Similar to our 
studies, previous studies also found that the SF-6D12, EQ-5D-3L, HUI2, and HUI3 
have similar measurement properties (Janssen et al, 2007; Bharmal et al, 2006; Luo et 
al, 2009). The better performance of SF-6D36 than other instruments is likely due to its 
classification system. On the basis of the results from this study, it seems that the 
components of the SF-6D36 are more optimal, as evaluated in a community sample. A 
fundamental difference between the SF-6D36 and other instruments is the use of 
descriptors for positive aspects of health (i.e. “a lot of energy” and “vigorous 
activities”) in the SF-6D36 classification system. Those positive health descriptors 
should be the reason for the minimal ceiling effects of the SF-6D36 and its ability to 
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detect variation in health that is beyond the measurement scope of other instruments.  
 
On the basis of a general population sample, our findings may not be generalized to 
patient populations. A number of studies compared the discriminative power of the 
SF-6D, EQ-5D-3L, HUI2, and/or HUI3 in patient populations and their findings 
varied depending on the (severity of) conditions investigated (Zhao et al, 2010; 
Hatoum et al, 2004; Marra et al, 2005; McTaggart-Cowan et al, 2008; Longworth et al, 
2003; Boonen et al, 2007; Hawthorne et al, 2001; Lamers et al, 2006; 
Kontodimopoulos, 2010). For example, the SF-6D36 was found to be more efficient 
than the EQ-5D-3L in patients with chronic prostatitis (Zhao et al, 2010) but less 
discriminative than the EQ-5D-3L and HUI3 in patients with rheumatoid arthritis 
(Marra et al, 2005). 
 
One limitation of our study is deriving the SF-6D12 from the SF-36. Respondents 
might have responded to the SF-12 questions differently if it had been administered as 
a stand-alone questionnaire. Nevertheless, Ware et al suggested that there was a high 
correlation between isolated SF-12 questions and the SF-12 items embedded in the 
SF-36 (r = 0.999) (Ware JE et al, 1998). Another limitation is that the study sample 
did not include individuals younger than 35 years of age. Thus, our findings may not 
be generalized to the very young adult population. Very young adults are generally 
either in full health or only in early stages of chronic conditions, if any.  
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In conclusion, the SF-36 provides a more discriminative preference-based health 
index than the SF-12. Findings from our study support the use of the SF-6D score 
derived from the SF-36 in population health surveys where a preference-based health 
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Chapter Seven - Conclusions 
Major Findings 
I conducted several studies to address research questions on measuring HSUs. Major 
findings of these studies are as follows: 
 
1. The utility of EQ-5D-5L health states is higher to mainland Chinese than to 
Singaporean Chinese.  
 
2. The utility of mild EQ-5D-3L health states is higher to T2DM patients than to 
the general population and therefore the EQ-5D-3L values based on the general 
population‟s preferences could be insensitive to the benefits of and underestimate the 
effectiveness of health inventions for T2DM. 
 
3. The values of EQ-5D-3L health states estimated using the TTO method in 
Singapore are lower and vary greater than those EQ-5D-3L values from other 
countries. Therefore, using EQ-5D-3L value sets from other countries would 
underestimate the health gain and cost-effectiveness of health interventions in 
Singapore. 
 
4. The preference-based SF-6D36 index score can be generated from the SF-8 
health survey.  
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5. The SF-6D index score derived from the SF-36 is more efficient than that 
derived from the SF-12 as well as three other commonly used preference-based health 
indices (i.e. EQ-5D-3L, HUI2, and HUI3) in discriminating between individuals in 
different health conditions. 
 
Contributions 
This thesis has contributed new knowledge to the understanding on HSU 
measurement for CUA. The main contributions are summarized as follows: 
 
1. The difference in TTO values of EQ-5D-5L health states between mainland 
Chinese and Singaporean Chinese could lead to different CUA results if one 
population‟s preferences are used to the other population. Hence, the development of 
local EQ-5D-5L value sets is supported.  
 
2. The utility of mild EQ-5D-3L health states are higher to T2DM patients than 
to the general population and therefore the EQ-5D-3L values based on the general 
population‟s preferences could be insensitive to the benefits of and underestimate the 
effectiveness of health inventions for T2DM. Hence, it might be worthwhile to 
determine the values of the EQ-5D-3L health states to patients with a certain 
condition and use patients‟ values to inform clinical decision making for the relevant 
disease. 
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3. The established EQ-5D-3L value set provides health services researchers a 
useful tool to appraise the cost-effectiveness of health technologies or interventions in 
Singapore.  
 
4. The functions developed for predicting the preference-based SF-6D36 index 
score from the psychometric instrument SF-8 enable the SF-8 data to be used in CUA.  
 
5. The result that the SF-6D derived from the SF-36 is more discriminative than 
that derived from the SF-12 supports the usage of the SF-6D index score derived from 
the SF-36 whenever possible when a preference-based index is needed.  
 
Future studies 
The studies performed have also raised some new research questions worth exploring 
in future studies. These are: 
 
1. Previously, researchers had to use the UK, US, or Japanese EQ-5D-3L value 
set to obtain utility scores in Singapore as there was no local EQ-5D-3L value set. 
Since we have established the local value set, future studies need to compare the 
Singapore EQ-5D-3L values with the values from other countries and to explore the 
impact of using other countries‟ values on CUAs in Singapore.  
 
2. Future studies need to evaluate the performance of DCE in eliciting HSU 
values. Compared to prevailing valuation techniques (i.e. SG and TTO), the DCE is 
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simpler and its values are less likely to be affected by factors other than preferences 
for health states. It is a promising tool in health-state valuation.  
 
    3. The EQ-5D-5L is a new version of the EQ-5D-3L, which has the same 5 
domains as the EQ-5D-3L, but comprises 5 functional levels including no problem 
(level 1), slight problems (level 2), moderate problems (level 3), severe problems 
(level 4), and extreme problems (level 5). Currently, the EQ-5D-5L index score can be 
obtained by applying the indirect mapping method from the EQ-5D-3L to the 
EQ-5D-5L. Future studies need to develop EQ-5D-5L value sets based on directly 
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